<!doctype html><html><head><meta charset=utf-8><title>Vitamin D associations with erectile dysfunction</title>
<link rel=stylesheet href="/css/main.css?v=1752030351"><link rel=stylesheet href="/css/pagination.css?v=1752030351"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1752030351"></script><script src="/js/search.js?v=1752030351"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>Vitamin D associations with erectile dysfunction</h1><time>April 25, 2012</time><div data-pagefind-body><p>Rough copy from <a href="http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/?show_full_text=true">/dermatoendocrinology</a></p><p>scroll down to see the actual paper</p><!doctype html><html xmlns=http://www.w3.org/1999/xhtml xml:lang=en lang=en><head><meta charset=utf-8><script type=text/javascript>var NREUMQ=NREUMQ||[];NREUMQ.push(["mark","firstbyte",(new Date).getTime()])</script><p><b>Landes Bioscience Journals: Dermato-Endocrinology</b></p><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/screen.v1240858290.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/screen.v1238959200.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/base.v1299870894.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/main_style.v1317147690.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/jquery-ui-1.8.1.custom.v1291582501.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/superfish.v1233794143.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/generated_style.v1310666403.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/user_journal_edboard.v1248984687.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/prettyPhoto.v1291582683.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/disqus_hide_post_box.v1296153969.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/user_journal.v1330718755.css"><link rel=stylesheet type=text/css media="screen, projection" href="./dertmato 7_files/thickbox.v1233793846.css"><link rel=stylesheet type=text/css media=print href="./dertmato 7_files/print.v1301688685.css"><!--[if IE]><link rel=stylesheet type=text/css media="screen, projection" href=/css/blueprint/ie.v1238959200.css><![endif]--><!--[if IE]><link rel=stylesheet type=text/css media="screen, projection" href=/css/ie_main_style.v1301587202.css><![endif]--><link rel=icon href=http://www.landesbioscience.com/images/favicon.ico type=image/x-icon><link rel="shortcut icon" href=http://www.landesbioscience.com/images/favicon.ico type=image/x-icon><script type=text/javascript>var gaJsHost="https:"==document.location.protocol?"https://ssl.":"http://www.";document.write(unescape("%3Cscript src='"+gaJsHost+"google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"))</script><script src="./dertmato 7_files/ga.js" type=text/javascript></script><script type=text/javascript>try{var pageTracker=_gat._getTracker("UA-11960531-1");pageTracker._setDomainName(".landesbioscience.com"),pageTracker._trackPageview()}catch{}</script><script type=text/javascript src="./dertmato 7_files/jquery-1.4.2.min.v1291582749.js"></script><script type=text/javascript src="./dertmato 7_files/jquery-ui-1.8.1.custom.min.v1291582504.js"></script><script type=text/javascript src="./dertmato 7_files/jquery.livequery.v1233793846.js"></script><script type=text/javascript src="./dertmato 7_files/hoverIntent.v1233794143.js"></script><script type=text/javascript src="./dertmato 7_files/supersubs.v1233794143.js"></script><script type=text/javascript src="./dertmato 7_files/jquery.bgiframe.min.v1233794143.js"></script><script type=text/javascript src="./dertmato 7_files/superfish.v1233794143.js"></script><script type=text/javascript src="./dertmato 7_files/site2.v1314294747.js"></script><script type=text/javascript src="./dertmato 7_files/jquery.prettyPhoto.v1291582683.js"></script><script type=text/javascript src="./dertmato 7_files/thickbox.v1233793846.js"></script><script type=text/javascript src="./dertmato 7_files/jquery.throbber.v1233793848.js"></script><script type=text/javascript src="./dertmato 7_files/jquery.selectboxes.v1233793848.js"></script><script type=text/javascript src="./dertmato 7_files/rotator.v1249330610.js"></script><script type=text/javascript src="./dertmato 7_files/jquery.uri.v1233794143.js"></script><script type=text/javascript src="./dertmato 7_files/user_journals.v1334685394.js"></script></head><link rel=stylesheet type=text/css href=data:text/css,><body style=width:1250px><div id=landes_page><div class=container><div class=span-24><div class="landes_masthead span-24"><div class=span-3><a href=http://www.landesbioscience.com/><img id=landes_logo src="./dertmato 7_files/landes_logo_medium.gif"></a></div><div class=span-17><div id=landes_masthead_north style=height:91px><div id=landes_masthead_north_logo></div></div><div id=landes_masthead_center><div id=landes_main_nav class="landes_top_nav landes_top_nav_color"><ul class="landes_main_menu sf-js-enabled"><li class=first><a href=http://www.landesbioscience.com/>Home</a></li><li><a href=http://www.landesbioscience.com/journals/ id=landes_main_nav_journals>Journals</a><ul style=width:470px;padding-top:5px;padding-right:0;padding-bottom:5px;padding-left:0;display:none;visibility:hidden><div style="float:left!important;border-right:1px solid #c6d0ce;padding-right:10px"></div><div style=float:left!important></div></ul></li><li><a href="http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/?show_full_text=true#" id=landes_main_nav_books>Books</a><ul style=padding-top:5px;padding-right:0;padding-bottom:5px;padding-left:0;display:none;visibility:hidden><li><a href=http://www.landesbioscience.com/books/iu/>Intelligence Unit</a></li><li><a href=http://www.landesbioscience.com/books/special/>Special Books</a></li><li><a href=http://www.landesbioscience.com/books/vademecum/>Vademecum Medical Handbooks</a></li></ul></li><li><a href=http://www.landesbioscience.com/curie/>Madame Curie Database</a></li><li><a href=http://www.landesbioscience.com/contact/>Contact</a></li><li><a href=http://www.landesbioscience.com/support/request/>Support</a></li><li><a href=http://www.landesbioscience.com/journals/libraries/>For Librarians</a></li><li><a href=http://www.landesbioscience.com/ipad/about/>iPad</a></li></ul></div></div></div><div class="span-4 last"><div id=landes_masthead_east><div id=landes_login_nav class="pull-4 span-8 last"><ul><li><a href=http://www.landesbioscience.com/login/>Login</a></li></ul><br><ul></ul></div><div id=landes_search_nav class="span-5 last"></div></div></div></div><div id=landes_masthead_south class=span-24><div id=landes_sub_nav class=j_subnav><ul class=landes_sub_menu></div></div><div class="landes_content span-24"><div class="span-20 prepend-top append-bottom"><div class=landes_content_center><h4 class=shorter>Review</h4><h2 id=article_title class="j_color1 shorter">Does vitamin D deficiency contribute to erectile dysfunction?</h2><div class="span-13 append-1"><a id=issue_url href=http://www.landesbioscience.com/journals/dermatoendocrinology/toc/volume/4/issue/2/><p>Volume 4, Issue 2</a>   April/May 2012<br></p><p><b>Keywords</b>: calcification, diabetes, erectile dysfunction, hypertension, inflammation, nitric oxide, peripheral arterial disease, vascular diseases, vasodilation, Vitamin D<br></p><h5 id=author_commalist class=shorter style=font-weight:400;display:inline><b>Authors</b>: Marc Sorenson and William B. Grant</h5><br><a href="http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/?show_full_text=true#" class=author_toggle>View affiliations</a> <a href="http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/?show_full_text=true#" class=author_toggle style=display:none>Hide affiliations</a><dl id=author_fulllist style=display:none><dt>Marc Sorenson</dt><dd><p>Corresponding author: <a href=mailto:megamarc1@aol.com><a href=mailto:megamarc1@aol.com>megamarc1@aol.com</a></a><br></p><p>Sunlight Institute; Saint George, UT USA</p></dd><dt>William B. Grant</dt><dd><p>Sunlight, Nutrition, and Health Research Center; San Francisco, CA USA</p></dd></dl><p><br><br></p><p id=abstract><p>Erectile dysfunction (ED) is a multifactorial disease, and its causes can be neurogenic, psychogenic, hormonal and vascular. ED is often an important indicator of cardiovascular disease (CVD) and a powerful early marker for asymptomatic CVD. Erection is a vascular event, and ED is often a vascular disease caused by endothelial damage and subsequent inhibition of vasodilation. We show here that risk factors associated with a higher CVD risk also associate with a higher ED risk. Such factors include diabetes mellitus, hypertension, arterial calcification and Inflammation in the vascular endothelium. Vitamin D deficiency is one of several dynamics that associates with increased CVD risk, but to our knowledge, it has not been studied as a possible contributor to ED. Here we examine research linking ED and CVD and discuss how vitamin D influences CVD and its classic risk factors—factors that also associate to increased ED risk. We also summarize research indicating that vitamin D associates with reduced risk of several nonvascular contributing factors for ED. We conclude that VDD contributes to ED. This hypothesis should be tested through observational and intervention studies.</p></p></div><div id=links_box class="span-6 last"><h4 class="large shorter"><img src="./dertmato 7_files/download.png" style=position:relative;top:6px> Purchase or Subscribe</h4><div style="background:#f2faf8;border:1px solid #ddd;padding:18px 12px"><p>The pdf of this article is not yet available for download. Check back soon.<br><br></p><p><a href=http://www.landesbioscience.com/journals/dermatoendocrinology/subscribe/>Subscribe to <i>Dermato-Endocrinology</i></a></p><p><br><br></p><p><a href=http://www.landesbioscience.com/recommend/>Recommend this Publication</a></p><p><br><br></p><p><a href=http://www.landesbioscience.com/login/>Subscriber Login</a></p><p><br><br></p><hr><p><a href="http://www.facebook.com/sharer.php?u=http%3A%2F%2Fwww.landesbioscience.com%2Fjournals%2Fdermatoendocrinology%2Farticle%2F20361%2F%3Fshow_full_text%3Dtrue" target=_blank style=display:block;margin-bottom:5px><img src="./dertmato 7_files/facebook_24.png" style=position:relative;top:7px> Share on Facebook</a></p><br><p><a href="http://www.linkedin.com/shareArticle?mini=true&url=http%3A%2F%2Fwww.landesbioscience.com%2Fjournals%2Fdermatoendocrinology%2Farticle%2F20361%2F&title=Does+vitamin+D+deficiency+contribute+to+erectile+dysfunction%3F&summary=Erectile%20dysfunction%20(ED)%20is%20a%20multifactorial%20disease,%20and%20its%20causes%20can%20be%20neurogenic,%20psychogenic,%20hormonal%20and%20vascular.%20ED%20is%20often%20an%20important%20indicator%20of%20cardiovascular%20disease%20(CVD)%20and%20a" target=_blank><img src="./dertmato 7_files/linkedin.png"></a></p><p><br><br></p><p><a href="https://twitter.com/share?url=http://www.landesbioscience.com/journals/dermatoendocrinology/article/20361/&text=Dermato-Endocrinology:%20Does%20vitamin%20D%20deficiency%20contribute%20to%20erectile%20dysfunction?" class=twitter-share-button><img src="./dertmato 7_files/tweet_button.png"></a></p></div></div><div style="margin:20px 0;width:100%;height:25px;background-color:#f2faf8;float:left"><h3>Full Text</h3></div><input type=hidden id=journal_short_name value=dermatoendocrinology><div id=full_text style=width:760px;float:left align=justify><img src="./dertmato 7_files/delete.png" style=display:inline role=.section_1><h4 class=section_title style=color:#654d3e><b>Introduction: Important facts pertaining to this discussion</b></h4><br><br><div class=section_1><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D is a steroid hormone produced in human skin by sunlight stimulation, specifically the UV-B (UVB) portion of the sunlight spectrum; about 80% of vitamin D is thus obtained.<xref ref-type=bibr rid=R1 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>1</sup></xref> The angle of sunlight varies greatly by season. In summer, the sun is overhead at noon, but in winter it stays closer to the horizon, and sunlight must pass through more atmosphere, which filters out much or all of the UVB. Therefore, availability of UVB exposure, and its resultant vitamin D production in skin, is highest in late spring through early fall and lowest from late fall through early spring. Consequently, vitamin D levels in the bloodstream also vary by season, with levels highest in late spring through early fall and lowest from late fall through early spring. For example, vitamin D levels in the UK are about 50% higher at the end of summer than at the end of winter.<xref ref-type=bibr rid=R1 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>1</sup></xref></p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D deficiency (VDD) has increased profoundly in the last two decades. According to data from the National Health and Nutrition Examination Survey (NHANES), 45% of the US population had serum vitamin D levels of 30 ng/mL (considered adequate for health<xref ref-type=bibr rid=R2 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>2</sup></xref>) in 1998–1994, whereas in 2001–2004, this figure was only 23%, a drop of 49%.<xref ref-type=bibr rid=R3 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>3</sup></xref> Concomitantly, the incidence of erectile dysfunction (ED) is rising: worldwide, the number of men with ED will increase from 150 million in 1995 to an estimated 322 million in 2025.<xref ref-type=bibr rid=R4 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>4</sup></xref> ED is also prevalent in the US, affecting approximately 18–30 million men older than 20 y.<xref ref-type=bibr rid=R5 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>5</sup></xref><sup>,</sup><xref ref-type=bibr rid=R6 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>6</sup></xref> Much of the worldwide upsurge may be due to an aging population, a deteriorating diet, lack of exercise, and other unhealthful practices.</p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>One recent study found risk of ED associated with “body mass index (BMI), irritative lower urinary tract symptoms, diabetes mellitus, chronic obstructive pulmonary disease (COPD) and sexual inactivity.”<xref ref-type=bibr rid=R7 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>7</sup></xref></p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>“Most cases [of ED] have a multifactorial origin and it is admitted the influence on its pathogenesis of systemic diseases, different kind of drugs, psychogenic factors, cardiovascular, endocrinological and neurological diseases. Neurologic causes of erectile dysfunction may have their origins in the central or peripheral nervous system. Among possible process of neurogenic erectile dysfunction of central origin would be tumors, cerebral vascular accidents, encephalitis, Parkinson disease, multiple sclerosis and other demyelinization diseases, dementias, olivopontocerebellar degeneration and epilepsy.”<xref ref-type=bibr rid=R8 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>8</sup></xref></p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>It has been estimated that about half of ED is related to vascular causes.<xref ref-type=bibr rid=R9 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>9</sup></xref> VDD also contributes to ED apart from its negative influence on classic CVD risk factors.</p></div><img src="./dertmato 7_files/delete.png" style=display:inline role=.section_2><h4 class=section_title style=color:#654d3e><b>The role of vascular disorders in ED</b></h4><br><br><div class=section_2><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>ED is an inability to produce an erection sufficiently rigid for sexual intercourse. ED incidence increases with age; the most severe form (defined as never being able to achieve an erection) occurs in 2% of men aged 20–39 y, increasing to 47% of men aged 75 y.<xref ref-type=bibr rid=R10 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>10</sup></xref></p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The penis is a highly vascularized organ, and erections are primarily vascular events.<xref ref-type=bibr rid=R11 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>11</sup></xref> Sexual stimulation causes the release of neurotransmitters from the corpus cavernosa (the two cylindrical chambers that run the length of the penis) and a relaxing factor, now established as nitric oxide (NO), from the endothelial cells of the penis.<xref ref-type=bibr rid=R12 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>12</sup></xref> NO is particularly important; vasodilation is essential to erection, and NO is the trigger for vasodilation in the vascular endothelium.<xref ref-type=bibr rid=R13 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>13</sup></xref><sup>,</sup><xref ref-type=bibr rid=R14 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>14</sup></xref> The neurotransmitters, together with NO, cause the corpus cavernosa to relax and allow blood to flow into the penis, causing the penis to expand and sustain an erection until the process is reversed.<xref ref-type=bibr rid=R15 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>15</sup></xref> Any disorder causing endothelial dysfunction (END) will also interfere with vasodilation, which prevents erection. END is an early marker for the development of atherosclerosis.<xref ref-type=bibr rid=R16 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>16</sup></xref> In fact, END is the key factor in the pathophysiology of ED, and men with penile END also have END in other blood vessels.<xref ref-type=bibr rid=R17 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>17</sup></xref></p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The increase in the number of patients with CVD risk factors parallels the worldwide increase in ED prevalence,<xref ref-type=bibr rid=R18 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>18</sup></xref> which one would expect given that the two disorders result from intertwined disease processes.<xref ref-type=bibr rid=R19 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>19</sup></xref> Although nonvascular factors such as depression, fatigue, stress, Parkinson disease, multiple sclerosis (MS), and hypertensive medications may affect ED,<xref ref-type=bibr rid=R12 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>12</sup></xref> it is primarily a vasculogenic disease. Its most prevalent cause is the arterial occlusion of atherosclerosis, which also affects the coronary arteries and can lead to heart attack<xref ref-type=bibr rid=R11 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>11</sup></xref> or, in other parts of the body, vascular events such as stroke<xref ref-type=bibr rid=R20 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>20</sup></xref> and peripheral arterial disease (PAD).<xref ref-type=bibr rid=R21 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>21</sup></xref></p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Because the penile arteries are smaller than arteries supplying other areas of the body, the first symptoms of atherosclerosis may manifest as ED, making ED one of the best predictors of CVD.13<sup>,22,23,24,25</sup> Coronary artery disease is a CVD that is highly predictable by the presence of ED. Jackson and colleagues have stated that after the onset of ED, many men experience CVD symptoms in 2–3 y and then suffer cardiovascular events (such as heart attack or stroke) in 3–5 y.<xref ref-type=bibr rid=R26 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>26</sup></xref> One CVD, PAD, is also associated with the presence of ED. ED is an independent predictor of PAD, and increasing severity of ED is associated with increasing prevalence of PAD.<xref ref-type=bibr rid=R27 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>27</sup></xref></p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Bohm and colleagues, after conducting a 2 y, randomized, controlled trial to determine whether ED was a harbinger of CVD events, demonstrated that ED was a potent predictor of myocardial infarction, stroke, and heart failure in men with preexisting CVD. ED also predicted an increased hazard ratio of 1.84 (95% confidence interval, 1.21–2.81; p = 0.005) for all-cause death.<xref ref-type=bibr rid=R28 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>28</sup></xref> In discussing the results of this study and the danger that ED drugs (phosphodiesterase-5 inhibitors) might pose by causing ED patients to ignore the presence of CVD, Bohm observed the following: “The drug works and the patient doesn’t show up anymore. These men are being treated for ED, but not the underlying cardiovascular disease. A whole segment of men is being placed at risk.”<xref ref-type=bibr rid=R29 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>29</sup></xref> Other researchers have concluded that the presence of ED should trigger an aggressive assessment for occult vascular disease.<xref ref-type=bibr rid=R11 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>11</sup></xref></p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Because both CVD and ED are, at least in part, vascular diseases, and ED is a potent predictor of CVD, the presence of risk factors for CVD also predicts the presence of ED,<xref ref-type=bibr rid=R30 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>30</sup></xref> and treatments that improve CVD often also do so for ED. Treatments with lifestyle changes, for example, are quite effective. Gupta and colleagues performed a meta-analysis of randomized, controlled clinical trials and demonstrated that with lifestyle modification and CVD risk-factor reduction programs in men with ED, sexual function increased by 2.4 times with lifestyle changes alone and by 2.66 times when statin therapy was included.<xref ref-type=bibr rid=R31 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>31</sup></xref> One effect of some statins is an increase in serum 25(OH)D concentrations<xref ref-type=bibr rid=R32 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>32</sup></xref></p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>One effective lifestyle change included a diet rich in whole grains, fruits, vegetables, legumes, walnuts, and olive oil; another was an exercise program (running or vigorous outdoor activity). Optimizing vitamin D levels through sunlight exposure or supplementation was not part of the lifestyle changes, but it should have been: VDD is associated with arterial stiffness and vascular dysfunction.<xref ref-type=bibr rid=R33 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>33</sup></xref><sup>,</sup><xref ref-type=bibr rid=R34 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>34</sup></xref> Vasculogenic ED results from impaired smooth-muscle relaxation (endothelial-dependent-or-independent), occlusion of the cavernosal arteries by atherosclerosis, or both.<xref ref-type=bibr rid=R17 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>17</sup></xref></p></div><img src="./dertmato 7_files/delete.png" style=display:inline role=.section_3><h4 class=section_title style=color:#654d3e><b>The role of vitamin D and sunlight on CVD</b></h4><br><br><div class=section_3><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>VDD is rampant among heart disease patients; University of Kansas researchers found that 70.3% of their heart disease patients had serum vitamin D levels below 30 ng/mL (the measure considered adequate for health) and that supplemental vitamin D was associated with a 61% reduction in the risk of death.<xref ref-type=bibr rid=R35 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>35</sup></xref> Giovannucci and colleagues showed that men with the lowest levels of serum vitamin D had a 2.4-times-increased risk of heart attack.<xref ref-type=bibr rid=R36 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>36</sup></xref></p></div><img src="./dertmato 7_files/delete.png" style=display:inline role=.section_4><h4 class=section_title style=color:#654d3e><b>Possible influence of sunlight or vitamin D on four major risk factors for CVD and ED</b></h4><br><br><div class=section_4><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>We hypothesize that optimizing vitamin D levels in men with ED could achieve similar positive influences on that disease. We first discuss four classic risk factors for CVD and ED and present research suggesting the influence of sunlight or vitamin D on each factor. We then briefly discuss other influences of vitamin D on ED that have not been thoroughly covered in conjunction with the four common risk factors discussed.</p><sec xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table><p><b>Arterial calcification</b></p><p>Arterial calcification is a common feature of atherosclerosis, occurring in more than 90% of angiographically significant lesions.<xref ref-type=bibr rid=R37 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>37</sup></xref> Measures of arterial calcification have been used since 1964 to predict myocardial infarct,<xref ref-type=bibr rid=R38 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>38</sup></xref> and in 1990, 83–90% of CVD patients showed calcification of their coronary arteries—a far higher percentage than disease-free people.<xref ref-type=bibr rid=R39 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>39</sup></xref> Arterial calcification remains a strong marker of increased risk of CVD,<xref ref-type=bibr rid=R40 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>40</sup></xref><sup>,</sup><xref ref-type=bibr rid=R41 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>41</sup></xref> independent of other known risk factors.<xref ref-type=bibr rid=R42 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>42</sup></xref><sup>,</sup><xref ref-type=bibr rid=R43 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>43</sup></xref></p><p>Arterial calcification is also a risk factor for ED. Lee and colleagues demonstrated that men who had ED were about 40% more likely to have measurable coronary artery calcification than those without ED.<xref ref-type=bibr rid=R44 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>44</sup></xref> They concluded that ED “is significantly associated with abnormal coronary artery calcification and, like PAD, might warrant consideration as a coronary artery disease risk equivalent.”</p><p>Serum vitamin D levels and arterial calcification have a strong inverse relationship,<xref ref-type=bibr rid=R37 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>37</sup></xref> provided that vitamin D levels are not excessively high, which can exacerbate calcification. Zittermann and colleagues explain that vitamin D exerts a biphasic dose–response curve on vascular calcification with deleterious consequences not only for vitamin D excess but also for VDD. They also note, however, that vitamin D excess seldom occurs in the general population.<xref ref-type=bibr rid=R45 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>45</sup></xref> These researchers also mention that in rats, low levels of activated vitamin D (1,25-dihydroxyvitamin D or calcitriol) are associated with massive calcification of blood vessels and other soft tissues.</p><p>We hypothesize that optimizing vitamin D levels through sunlight exposure or supplementation would have positive benefits for those suffering from ED associated with vascular calcification.</p><p></sec><sec xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table></p><p><b>Diabetes mellitus</b></p><p>Diabetes mellitus (DM) is a disorder of carbohydrate metabolism characterized by excessive glucose levels in urine due either to inadequate production of insulin (insulin-dependent, or type 1 DM) or to poor insulin utilization (adult-onset, or type-2 DM), both of which result in increased urine flow. Ninety percent to 95% of diabetes cases in the US are type2.<xref ref-type=bibr rid=R46 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>46</sup></xref> The presence of DM is a profound predictor of CVD, correlating to an increased risk of CVD of approximately 2.5 times.<xref ref-type=bibr rid=R47 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>47</sup></xref> Although incidence of CVD has decreased somewhat in the past few decades, it has done so only in those without DM. The incidence of DM rapidly increased from 1970 to 2000,<xref ref-type=bibr rid=R48 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>48</sup></xref> especially during the 1990s, and those with DM have shown a dramatic upsurge in the risk of CVD. For example, during the 1990s, the risk of acute myocardial infarction increased among those with DM by 51%, and general CVD rates in men with DM increased by 61%.<xref ref-type=bibr rid=R49 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>49</sup></xref> Diabetes leads to CVD by causing END, a precursor to atherosclerosis, as follows:<xref ref-type=bibr rid=R50 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>50</sup></xref> High levels of glucose in the blood inhibit the production of NO.<xref ref-type=bibr rid=R51 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>51</sup></xref> This inhibition impairs vasodilation of vessels and leads to atherosclerosis<xref ref-type=bibr rid=R52 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>52</sup></xref> by promoting vasoconstriction, hypertension, vascular smooth-muscle growth, inflammation, expression of cellular adhesion molecules (CAMs), platelet activation, decreased fibrinolysis, and thrombosis.<xref ref-type=bibr rid=R53 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>53</sup></xref> Both type 1 and type 2 DM follow this pattern. Awad and colleagues stated that “the diabetes control and complications trial clearly showed that better long-term control of blood glucose in diabetes type 1 is associated with decreased frequency and delayed the onset of microvascular complications.”<xref ref-type=bibr rid=R54 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>54</sup></xref> These changes in the vessel walls affect the brain as well as the heart: diabetics younger than 55 y have 11.6 times the risk of stroke.<xref ref-type=bibr rid=R55 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>55</sup></xref></p><p>DM also is associated closely with the risk of ED, as one would expect given how DM damages the vascular system. Reviewing the literature, Phe and Roupret concluded that “the pathophysiology is multifactorial, involving END, specific complications of diabetes and psychological factors.”<xref ref-type=bibr rid=R56 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>56</sup></xref> In fact, compared with nondiabetic men, men with DM have three to four times the risk of ED,<xref ref-type=bibr rid=R57 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>57</sup></xref><sup>,</sup><xref ref-type=bibr rid=R58 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>58</sup></xref> and the likelihood of ED in diabetic men ranges from 35–90%.<xref ref-type=bibr rid=R59 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>59</sup></xref> ED in men with diabetes also occurs 10–15 y earlier.<xref ref-type=bibr rid=R60 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>60</sup></xref></p><p>Sunlight exposure relates to DM. One paper showed that blood sugar levels are lower during summer than in winter,<xref ref-type=bibr rid=R61 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>61</sup></xref> and another showed that exposure to UVB light increases insulin secretion.<xref ref-type=bibr rid=R62 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>62</sup></xref></p><p>Vitamin D research indicates a close association between vitamin D and DM. Pittas and colleagues reported on research conducted on adults with impaired sugar tolerance and insulin resistance (both risk factors for diabetes). For 3 y, half received a placebo and the other half received vitamin D plus calcium. The rise in blood sugar levels was 15 times higher in the placebo group, and their increase in insulin resistance was 18 times higher.<xref ref-type=bibr rid=R63 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>63</sup></xref> Moreover, a 4-week program of high-dose vitamin D supplementation (10,000 IU daily) in subjects with impaired fasting glucose was associated with an improved insulin sensitivity and a decreased acute insulin response to glucose, both risk factors for DM.<xref ref-type=bibr rid=R64 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>64</sup></xref> Finally, a 16-week randomized, placebo-controlled study demonstrated that subjects who took 2,000 IU of vitamin D<sub>3</sub> daily had increased ?-cell function, as shown by a 37% improvement in insulin secretion.<xref ref-type=bibr rid=R65 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>65</sup></xref></p><p>We hypothesize that vitamin D optimization through sunlight exposure and/or vitamin D<sub>3</sub> supplementation would decrease END and subsequent vascular damage caused by diabetes and would reduce the risk of ED.</p><p></sec><sec xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table></p><p><b>Hypertension and stroke</b></p><p>High blood pressure, or hypertension, especially systolic pressure, is a vascular disorder that is a potent predictor of CVD,<xref ref-type=bibr rid=R66 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>66</sup></xref> and a strong, linear, and independent relationship exists between the two.<xref ref-type=bibr rid=R67 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>67</sup></xref> Hypertension is also one of the most important risk factors for stroke.<xref ref-type=bibr rid=R68 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>68</sup></xref><sup>,</sup><xref ref-type=bibr rid=R69 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>69</sup></xref> Hypertension leads to END, which is mediated by impaired NO availability after oxidative stress.<xref ref-type=bibr rid=R16 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>16</sup></xref></p><p>Hypertension is also a risk factor for ED,<xref ref-type=bibr rid=R70 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>70</sup></xref> which afflicts to some degree 68% of men with hypertension.<xref ref-type=bibr rid=R71 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>71</sup></xref><sup>,</sup><xref ref-type=bibr rid=R72 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>72</sup></xref> Because hypertension leads to vascular damage and END, one would expect this outcome. The hypertension–ED–stroke connection is clear in the fact that over a 5-y period, men with ED have a 29% higher risk of stroke than those without ED.<xref ref-type=bibr rid=R73 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>73</sup></xref></p><p>The control of renin and angiotensin also affects hypertension. Renin is an enzyme that profoundly raises blood pressure by activating the peptide angiotensin, a vasoconstrictor.<xref ref-type=bibr rid=R74 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>74</sup></xref> Vitamin D may suppress hypertension by modulating the renin–angiotensin system,<xref ref-type=bibr rid=R75 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>75</sup></xref><sup>,</sup><xref ref-type=bibr rid=R76 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>76</sup></xref> a regulatory cascade essential in regulating blood pressure.<xref ref-type=bibr rid=R77 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>77</sup></xref> Vitamin D is a potent endocrine suppressor of renin biosynthesis, and VDD stimulates renin expression in normal mice.<xref ref-type=bibr rid=R75 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>75</sup></xref> Also, mice lacking vitamin D receptors produce more renin and angiotensin, leading to hypertension.<xref ref-type=bibr rid=R77 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>77</sup></xref></p><p>A direct relationship exists among hypertension, sunlight exposure, and stroke; the incidence of hypertension is considerably higher in winter than summer. One study of elderly hypertensive subjects showed that blood pressure levels averaged 165/90 in winter but 134/74 in the summer, and both stroke and heart attack rates doubled in winter.<xref ref-type=bibr rid=R78 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>78</sup></xref> Hypertension also follows the same pattern in children.<xref ref-type=bibr rid=R79 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>79</sup></xref> UVB light from sun lamps also effectively treats hypertension. In subjects who participated in three sessions per week of whole-body UVB exposure, vitamin D levels rose 162% after 6 weeks, and blood pressure dropped six points on both systolic and diastolic measurements.<xref ref-type=bibr rid=R80 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>80</sup></xref></p><p>Sunlight exposure’s ability to lower blood pressure may also be due to another spectrum of UV light—UVA. Opländer and colleagues demonstrated that whole-body irradiation with UVA lowered systemic blood pressure by stimulating NO production, significantly increasing intradermal levels of NO. These increased NO levels were accompanied by increased flow-mediated vasodilation of the brachial artery.<xref ref-type=bibr rid=R81 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>81</sup></xref> Such vasodilation could also enhance sexual function in men by lessening ED. Another investigation showed that men with the lowest vitamin D levels also had 6.13 times the risk of developing hypertension; women with the lowest levels had 2.67 times the risk.<xref ref-type=bibr rid=R82 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>82</sup></xref> Other investigations show a close association between VDD and the likelihood of stroke.<xref ref-type=bibr rid=R83 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>83</sup></xref></p><p>We hypothesize that vitamin D optimization through sunlight exposure or vitamin D<sub>3</sub> supplementation would decrease vascular damage caused by hypertension and reduce the risk of ED.</p><p></sec><sec xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table></p><p><b>Inflammation in the vascular endothelium</b></p><p>Inflammation is a reaction of damaged tissue that manifests as redness, swelling, pain, tenderness, and heat. It is primarily a protective response against injury. Normal vascular endothelium has anti-inflammatory properties, but endothelial function is impaired in the presence of inflammatory conditions and increased oxidative stress.<xref ref-type=bibr rid=R17 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>17</sup></xref><sup>,</sup><xref ref-type=bibr rid=R84 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>84</sup></xref> When injurious agents persist or healing is disturbed, inflammation, tissue injury, and attempts at repair coexist. This combination of factors can lead to chronic inflammation, harming many body systems, including the vascular system.<xref ref-type=bibr rid=R85 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>85</sup></xref> Inflammation drives the formation, progression, and rupture of atherosclerotic plaques; it is one of the stimuli that cause CAMs to further recruit inflammatory blood monocytes that adhere to the endothelium, and through chemotactic stimulus by inflammatory proteins known as chemokines and inflammatory cytokines, enter between the endothelial cells and invade the intima of the blood vessel. In the intima, they mature into macrophages, which engulf lipids and create foam cells, leading to atherosclerotic lesions.<xref ref-type=bibr rid=R86 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>86</sup></xref><sup>,</sup><xref ref-type=bibr rid=R87 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>87</sup></xref> Macrophages also release growth factors that are destructive to blood vessels.<xref ref-type=bibr rid=R88 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>88</sup></xref><sup>-</sup><xref ref-type=bibr rid=R91 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>91</sup></xref><sup>,</sup> Even subclinical inflammation affects endothelial function and is involved in all stages of atherosclerosis.<xref ref-type=bibr rid=R17 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>17</sup></xref> Thus, the endothelium as well as the entire blood vessel is damaged, and atherosclerosis proceeds.</p><p>ED is also closely associated with inflammation. C-reactive protein (CRP), a major marker of inflammation, is significantly higher in patients with ED than in subjects without ED.<xref ref-type=bibr rid=R92 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>92</sup></xref><sup>,</sup><xref ref-type=bibr rid=R93 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>93</sup></xref> Interestingly, CRP itself reduces production of NO, leading to further vascular damage.<xref ref-type=bibr rid=R94 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>94</sup></xref> Also, CAMs are increased in men with ED who have not manifested cardiovascular risk factors or overt vascular damage.<xref ref-type=bibr rid=R95 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>95</sup></xref> Another marker of inflammation is tumor necrosis factor ? (TNF?), an inflammatory cytokine that is markedly elevated in men with ED and is another common link between ED and CVD.<xref ref-type=bibr rid=R96 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>96</sup></xref></p><p>Vitamin D may promote vascular health by inhibiting inflammation.<xref ref-type=bibr rid=R97 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>97</sup></xref> Vitamin D supplements and injections may lower CRP levels as much as 40%<xref ref-type=bibr rid=R98 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>98</sup></xref> and improve cytokine profiles; it inhibits the production of proinflammatory cytokines<xref ref-type=bibr rid=R99 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>99</sup></xref><sup>,</sup><xref ref-type=bibr rid=R100 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>100</sup></xref> while stimulating the production of anti-inflammatory cytokines.<xref ref-type=bibr rid=R100 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>100</sup></xref><sup>,</sup><xref ref-type=bibr rid=R101 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>101</sup></xref> One pro-inflammatory cytokine, TNF?, is inversely related to regular exposure to sunlight and artificial sources of UVB among women,<xref ref-type=bibr rid=R102 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>102</sup></xref> and the same is probably true for men. Two CAMs induced by TNF? are also significantly decreased after incubation with activated vitamin D.<xref ref-type=bibr rid=R103 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>103</sup></xref> In addition, Oh and colleagues have shown that in patients with type 2 diabetes, active vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake,<xref ref-type=bibr rid=R104 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>104</sup></xref><sup>,</sup><xref ref-type=bibr rid=R105 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>105</sup></xref> inhibiting the inflammatory atherosclerotic process described earlier.</p><p>We hypothesize that vitamin D optimization through sunlight exposure or vitamin D<sub>3</sub> supplementation would decrease vascular damage caused by inflammation and reduce the risk of ED. We searched pubmed.gov for evidence contradicting our hypothesis regarding VDD and ED but found none.</p><p></sec><sec xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table></p><p><b>Other influences of vitamin D on ED</b></p><sec><p><b>Endothelial-progenitor cells</b></p><p>Endothelial progenitor cells (EPCs) are necessary for maintaining the health of the arterial endothelium. VDD is associated with depletion of EPCs and consequent END in patients with type 2 DM.<xref ref-type=bibr rid=R106 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>106</sup></xref> This research also showed that VDD was associated with reduced vasodilation as measured by brachial artery flow–mediated dilation.</p></sec><sec><p><b>NO synthases</b></p><p>NO synthases (NOS) are a family of enzymes that catalyze the production of NO from <sc>l</sc>-arginine. Activated vitamin D stimulates the production of substantial quantities of NOS and NO in macrophages produced in response to tuberculosis,<xref ref-type=bibr rid=R107 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>107</sup></xref> in bone,<xref ref-type=bibr rid=R108 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>108</sup></xref> and in endothelial cells,<xref ref-type=bibr rid=R109 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>109</sup></xref> the last being vital to vascular dilation and thereby important to inhibiting ED. This behavior may explain why endothelium-derived, NO-evoked dilation is halved in arteries from vitamin D–deficient male rats.<xref ref-type=bibr rid=R110 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>110</sup></xref></p></sec><sec><p><b>PAD</b></p><p>PAD is a CVD that is closely associated with the presence of ED. Chua and colleagues have shown that VDD could be an easily correctable independent risk factor for PAD.<xref ref-type=bibr rid=R111 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>111</sup></xref></p></sec><sec><p><b>Platelet activation</b></p><p>Platelet activation by proinflammatory factors is another aspect of END. In experiments, vitamin D attenuates platelet activation while reducing the expression of two CAMs, VCAM-1 and MT1-MMP.<xref ref-type=bibr rid=R112 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>112</sup></xref> Researchers in Israel also identified 50 patients who had a heart attack or an episode of unstable angina, placing half of them on a regimen of 4,000 IU of vitamin D daily for 5 d. The vitamin D group showed a decrease in VCAM-1 as well as another inflammation marker, interleukin 6. The patients who did not receive vitamin D showed clear increases in both inflammation markers.<xref ref-type=bibr rid=R113 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>113</sup></xref> The researchers stated, “VCAM-1 is central to atherosclerotic plaque formation and [interleukin 6] is broadly associated with coronary risk.” Both studies indicate that vitamin D has actions that reduce END and thereby have a positive influence on ED.</p></sec><sec><p><b>Vascular smooth-muscle cell proliferation</b></p><p>Vascular smooth-muscle cell (VSMC) proliferation is part of the process of atherosclerosis. Vitamin D has an antiproliferative influence on VSMC,<xref ref-type=bibr rid=R114 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>114</sup></xref><sup>,</sup><xref ref-type=bibr rid=R115 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>115</sup></xref> which indicates antiatherosclerotic properties that may positively influence ED.</p></sec><sec><p><b>Vasodilation</b></p><p>Vasodilation is vital to achieving erection. VDD is inversely associated with flow-mediated vasodilation, END, and arterial stiffness irrespective of the traditional risk factors for CVD and ED<xref ref-type=bibr rid=R33 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>33</sup></xref> discussed here. Therefore, VDD—in addition to exacerbating the classical risk factors for CVD—may directly lead to ED.</p></sec><p></sec><sec xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table></p><p><b>Nonvascular conditions comorbid with ED and influenced by vitamin D</b></p><p>We have thus far discussed the relationship of ED to CVD and considered the influence of vitamin D levels or treatment on both disorders. Evidence in addition to that presented in this review in support of the hypothesis that VDD contributes to ED risk was sought by searching pubmed.gov for papers linking ED to sun exposure, race, and disorders linked to VDD, and whether animal models regarding vitamin D and ED had been conducted. No evidence linking ED to sun exposure was found. No animal model studies of ED and vitamin D were found. In a cross-sectional study in the United States in 2000 and 2001, the estimated prevalence of ED was “21.9% (95% CI, 18.8-24.9) in whites, 24.4% (95% CI, 18.4-30.5) in blacks, and 19.9% (95% CI, 13.9-25.9) in Hispanics.”<xref ref-type=bibr rid=R116 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>116</sup></xref> Another paper reported that Black and Hispanic men in the Boston area had 25% higher rate of ED, but attributed the finding to socioeconomic status rather than race<xref ref-type=bibr rid=R117 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>117</sup></xref></p><p>Several other nonvascular diseases and conditions are closely associated with both ED and VDD, strengthening the hypothesis that VDD contributes to ED and offering another avenue whereby vitamin D optimization might mitigate or reverse it. Those diseases and conditions include Alzheimer,<xref ref-type=bibr rid=R118 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>118</sup></xref><sup>,</sup><xref ref-type=bibr rid=R119 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>119</sup></xref> asthma,<xref ref-type=bibr rid=R120 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>120</sup></xref><sup>,</sup><xref ref-type=bibr rid=R121 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>121</sup></xref> chronic kidney disease,<xref ref-type=bibr rid=R122 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>122</sup></xref><sup>-</sup><xref ref-type=bibr rid=R124 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>124</sup></xref> depression,<xref ref-type=bibr rid=R125 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>125</sup></xref><sup>,</sup><xref ref-type=bibr rid=R126 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>126</sup></xref> falls and fractures,<xref ref-type=bibr rid=R127 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>127</sup></xref><sup>,</sup><xref ref-type=bibr rid=R128 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>128</sup></xref> metabolic syndrome,<xref ref-type=bibr rid=R129 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>129</sup></xref><sup>,</sup><xref ref-type=bibr rid=R130 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>130</sup></xref> MS,<xref ref-type=bibr rid=R131 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>131</sup></xref><sup>-</sup><xref ref-type=bibr rid=R134 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>134</sup></xref> obesity,<xref ref-type=bibr rid=R135 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>135</sup></xref><sup>,</sup><xref ref-type=bibr rid=R136 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>136</sup></xref> Parkinson,<xref ref-type=bibr rid=R137 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>137</sup></xref><sup>,</sup><xref ref-type=bibr rid=R138 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>138</sup></xref> periodontal disease,<xref ref-type=bibr rid=R139 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>139</sup></xref><sup>,</sup><xref ref-type=bibr rid=R140 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>140</sup></xref> psoriasis,<xref ref-type=bibr rid=R141 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>141</sup></xref><sup>,</sup><xref ref-type=bibr rid=R142 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>142</sup></xref> and smoking.<xref ref-type=bibr rid=R143 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>143</sup></xref><sup>,</sup><xref ref-type=bibr rid=R144 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>144</sup></xref><xref ref-type=table rid=T1 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">Table 1</xref> summarizes research regarding those diseases and conditions. For all of these diseases, VDD appears to be an important risk factor. Thus, avoiding VDD earlier in life may reduce the risk of ED. In addition, for some of the diseases such as atopic dermatitis<xref ref-type=bibr rid=R145 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>145</sup></xref><sup>,</sup><xref ref-type=bibr rid=R146 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>146</sup></xref> and multiple sclerosis, increasing vitamin D intake or production can reduce the symptoms and may also reduce the risk of ED.</p><fieldset><table-wrap id=T1 position=float><p><b><b>Table 1.</b> Evidence for influences of vitamin D on nonvascular diseases and conditions associated with ED</b></p><table><colgroup span=4><col colnum=1 colname=col1 colwidth=15.63%><col colnum=2 colname=col2 colwidth=56.42%><col colnum=3 colname=col3 colwidth=12.36%><col colnum=4 colname=col4 colwidth=15.59%><thead><tr><td valign=top align=center style=border-top-width:0;border-top-style:none;border-top-color:#222;border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Disease or condition</td><td valign=top align=center style=border-top-width:0;border-top-style:none;border-top-color:#222;border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Finding<break>(some measure of correlation)</break></td><td valign=top align=center style=border-top-width:0;border-top-style:none;border-top-color:#222;border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Reference</td><td valign=top align=center style=border-top-width:0;border-top-style:none;border-top-color:#222;border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Evidence for vitamin D<break>deficiency</break></td></tr></thead><tbody><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Alzheimer disease</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Loss of erection was reported in 53% of 55 male Alzheimer disease patients with a mean age of 70.25 y. Loss of erection is not related to degree of cognitive impairment, age, or depression.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R118 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">118</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R119 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">119</xref></p></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Asthma</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Subjects with asthma experienced a 1.9-fold (95% confidence interval [CI], 1.3–2.9; p = 0.002) increase in incident ED.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R120 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">120</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R121 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">121</xref></p></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Chronic kidney disease</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Prevalence of ED of various degrees was 87.7% among 73 patients with chronic kidney disease in Iran.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R122 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">122</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><xref ref-type=bibr rid=R123 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">123</xref>,<xref ref-type=bibr rid=R124 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">124</xref></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Depression</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Comorbid conditions ED and depression are highly prevalent in men, and men with high depression scores are nearly twice as likely to report ED than nondepressed men.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R125 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">125</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R126 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">126</xref></p></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Falls, fractures</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>ED (2.01; 95% CI, 1.30–3.09) was associated with increased risk of osteoporotic fractures in adjusted models.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R127 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">127</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R128 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">128</xref></p></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Metabolic syndrome</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Metabolic syndrome appears to be strongly related to ED.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R129 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">129</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R130 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">130</xref></p></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Multiple sclerosis</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>91% of men with multiple sclerosis report having symptoms of either ED or impotence.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><xref ref-type=bibr rid=R131 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">131</xref>,<xref ref-type=bibr rid=R132 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">132</xref></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><xref ref-type=bibr rid=R133 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">133</xref>,<xref ref-type=bibr rid=R134 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">134</xref></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Obesity</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Obesity in Taiwanese military conscripts predicted more than an 83-times-increased risk of ED.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R135 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">135</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R136 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">136</xref></p></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Parkinson disease</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>ED was severe in 54% of Parkinson cases and moderate in 26.6%.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R137 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">137</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R138 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">138</xref></p></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Periodontal disease</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Chronic periodontal disease was significantly more prevalent among men with mild ED (p = 0.004) and moderate to severe ED (p = 0.007) than in men without ED.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R139 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">139</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R140 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">140</xref></p></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Psoriasis</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Patients with ED were more likely to have been diagnosed with psoriasis before the index date than controls (odds ratio = 3.85; 95% confidence interval l = 2.72–5.44)</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R141 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">141</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R142 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">142</xref></p></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Smoking</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>In comparison with never smokers, the OR of ED was 2.41 for current smokers and 2.15 for ex-smokers and increased with duration of the habit.</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R143 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">143</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R144 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">144</xref></p></td></tr><tr><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>Atopic dermatitis</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222>cases were more likely to have prior AD than controls (OR = 1.60; 95% CI = 1.42–1.80, p &lt; 0.001) after multifactorial adjustment</td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R145 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">145</xref></p></td><td valign=top align=center style=border-bottom-width:0;border-bottom-style:none;border-bottom-color:#222><p><xref ref-type=bibr rid=R146 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; ">146</xref></p></td></tr></tbody></table><p></table-wrap></fieldset></p><p></sec></div><img src="./dertmato 7_files/delete.png" style=display:inline role=.section_5><h4 class=section_title style=color:#654d3e><b>Conclusion</b></h4><br><br><div class=section_5></p><p xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The research presented suggests that many common mechanisms underlie both CVD and ED, and that VDD is closely associated with both disorders. We hypothesize that optimizing serum vitamin D levels through sunlight exposure or vitamin D supplementation helps delay the onset of ED. Coupled with positive changes in lifestyle, such optimization may restore normal sexual function to some men. This hypothesis should be tested through observational and intervention studies. If proven by further research, such therapy would offer an alternative or complement to phosphodiesterase-5 inhibitors, which, though exceptionally effective and a first choice for treatment, have been associated with many negative side effects,<xref ref-type=bibr rid=R147 style="cursor: pointer; color: rgb(128, 64, 0); font-weight: bold; "><sup>147</sup></xref> and which, because of their efficacy in producing erections, may cause men with ED to ignore the possibility they might have occult underlying CVD.</p></div><img src="./dertmato 7_files/delete.png" style=display:inline role=.references><h4 class=section_title style=color:#654d3e><b>References</b></h4><br><br><div class=references><div id=R1>1.<p>Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, Zittermann A, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D, cardiovascular disease and mortality</article-title>.</p><p>Clin Endocrinol (Oxf) 2011;</p><p>75:575-84; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21682758 target=_blank>21682758</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1365-2265.2011.04147.x target=_blank>10.1111/j.1365-2265.2011.04147.x</a>.</p></div><br><div id=R2>2.<p>Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice</article-title>.</p><p>Autoimmun Rev 2010;</p><p>9:709-15; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20601202 target=_blank>20601202</a>; DOI: <a href=http://dx.doi.org/10.1016/j.autrev.2010.06.009 target=_blank>10.1016/j.autrev.2010.06.009</a>.</p></div><br><div id=R3>3.<p>Ginde AA, Liu MC, Camargo CA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004</article-title>.</p><p>Arch Intern Med 2009;</p><p>169:626-32; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19307527 target=_blank>19307527</a>; DOI: <a href=http://dx.doi.org/10.1001/archinternmed.2008.604 target=_blank>10.1001/archinternmed.2008.604</a>.</p></div><br><div id=R4>4.<p>Ayta IA, McKinlay JB, Krane RJ.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences</article-title>.</p><p>BJU Int 1999;</p><p>84:50-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/10444124 target=_blank>10444124</a>; DOI: <a href=http://dx.doi.org/10.1046/j.1464-410x.1999.00142.x target=_blank>10.1046/j.1464-410x.1999.00142.x</a>.</p></div><br><div id=R5>5.<p>Araujo AB, Hall SA, Ganz P, Chiu GR, Rosen RC, Kupelian V, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?</article-title>.</p><p>J Am Coll Cardiol 2010;</p><p>55:350-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20117441 target=_blank>20117441</a>; DOI: <a href=http://dx.doi.org/10.1016/j.jacc.2009.08.058 target=_blank>10.1016/j.jacc.2009.08.058</a>.</p></div><br><div id=R6>6.<p>McKinlay JB.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The worldwide prevalence and epidemiology of erectile dysfunction</article-title>.</p><p>Int J Impot Res 2000;</p><p>12:S6-11; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/11035380 target=_blank>11035380</a>; DOI: <a href=http://dx.doi.org/10.1038/sj.ijir.3900567 target=_blank>10.1038/sj.ijir.3900567</a>.</p></div><br><div id=R7>7.<p>Schouten BW, Bohnen AM, Dohle GR, Groeneveld FP, Willemsen S, Thomas S, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Risk factors for deterioration of erectile function: the Krimpen study</article-title>.</p><p>Int J Androl 2009;</p><p>32:166-75; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/18067566 target=_blank>18067566</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1365-2605.2007.00830.x target=_blank>10.1111/j.1365-2605.2007.00830.x</a>.</p></div><br><div id=R8>8.<p>Valles Antuña C, Fernández Gómez JM, Escaf S, Fernández-González F.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Neurogenic etiology in patients with erectile dysfunction</article-title>.</p><p>Arch Esp Urol 2008;</p><p>61:403-11; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/18581678 target=_blank>18581678</a>.</p></div><br><div id=R9>9.<p>Kloner RA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction and cardiovascular risk factors</article-title>.</p><p>Urol Clin North Am 2005;</p><p>32:397-402, v; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16291032 target=_blank>16291032</a>; DOI: <a href=http://dx.doi.org/10.1016/j.ucl.2005.08.005 target=_blank>10.1016/j.ucl.2005.08.005</a>.</p></div><br><div id=R10>10.<p>Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Predictors and prevalence of erectile dysfunction in a racially diverse population</article-title>.</p><p>Arch Intern Med 2006;</p><p>166:207-12; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16432090 target=_blank>16432090</a>; DOI: <a href=http://dx.doi.org/10.1001/archinte.166.2.207 target=_blank>10.1001/archinte.166.2.207</a>.</p></div><br><div id=R11>11.<p>Billups KL, Bank AJ, Padma-Nathan H, Katz SD, Williams RA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction as a harbinger for increased cardiometabolic risk</article-title>.</p><p>Int J Impot Res 2008;</p><p>20:236-42; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/18200018 target=_blank>18200018</a>; DOI: <a href=http://dx.doi.org/10.1038/sj.ijir.3901634 target=_blank>10.1038/sj.ijir.3901634</a>.</p></div><br><div id=R12>12.<p>Solomon H, Man JW, Jackson G.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator</article-title>.</p><p>Heart 2003;</p><p>89:251-3; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/12591819 target=_blank>12591819</a>; DOI: <a href=http://dx.doi.org/10.1136/heart.89.3.251 target=_blank>10.1136/heart.89.3.251</a>.</p></div><br><div id=R13>13.<p>Meldrum DR, Gambone JC, Morris MA, Meldrum DA, Esposito K, Ignarro LJ.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The link between erectile and cardiovascular health: the canary in the coal mine</article-title>.</p><p>Am J Cardiol 2011;</p><p>108:599-606; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21624550 target=_blank>21624550</a>; DOI: <a href=http://dx.doi.org/10.1016/j.amjcard.2011.03.093 target=_blank>10.1016/j.amjcard.2011.03.093</a>.</p></div><br><div id=R14>14.<p>Bird IM.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Endothelial nitric oxide synthase activation and nitric oxide function: new light through old windows</article-title>.</p><p>J Endocrinol 2011;</p><p>210:239-41; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21824899 target=_blank>21824899</a>; DOI: <a href=http://dx.doi.org/10.1530/JOE-11-0216 target=_blank>10.1530/JOE-11-0216</a>.</p></div><br><div id=R15>15.<p>Web MD Erectile Dysfunction Health Center. Erectile dysfunction: how an erection occurs. <a href=http://www.webmd.com/erectile-dysfunction/guide/how-an-erection-occurs>http://www.webmd.com/erectile-dysfunction/guide/how-an-erection-occurs</a>. Accessed October 29, 2011.</div><br><div id=R16>16.</p><p>Ghiadoni L, Taddei S, Virdis A.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Hypertension and endothelial dysfunction: therapeutic approach</article-title>.</p><p>Curr Vasc Pharmacol 2012;</p><p>10:42-60; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22112351 target=_blank>22112351</a>; DOI: <a href=http://dx.doi.org/10.2174/157016112798829823 target=_blank>10.2174/157016112798829823</a>.</p></div><br><div id=R17>17.<p>Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links</article-title>.</p><p>Eur Urol 2007;</p><p>52:1590-600; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/17707576 target=_blank>17707576</a>; DOI: <a href=http://dx.doi.org/10.1016/j.eururo.2007.08.004 target=_blank>10.1016/j.eururo.2007.08.004</a>.</p></div><br><div id=R18>18.<p>Nehra A.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions</article-title>.</p><p>Mayo Clin Proc 2009;</p><p>84:139-48; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19181648 target=_blank>19181648</a>; DOI: <a href=http://dx.doi.org/10.4065/84.2.139 target=_blank>10.4065/84.2.139</a>.</p></div><br><div id=R19>19.<p>Menezes A, Artham S, Lavie CJ, Milani RV, O’Keefe J.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction and cardiovascular disease</article-title>.</p><p>Postgrad Med 2011;</p><p>123:7-16; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21566411 target=_blank>21566411</a>.</p></div><br><div id=R20>20.<p>Kronzon I, Tunick PA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Aortic atherosclerotic disease and stroke</article-title>.</p><p>Circulation 2006;</p><p>114:63-75; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16818829 target=_blank>16818829</a>; DOI: <a href=http://dx.doi.org/10.1161/CIRCULATIONAHA.105.593418 target=_blank>10.1161/CIRCULATIONAHA.105.593418</a>.</p></div><br><div id=R21>21.<p>Stöppler MC, Lee D, Kulic D, Peripheral MD. Vascular Disease. Medicine Net.com. <a href=http://www.medicinenet.com/peripheral_vascular_disease/article.htm>http://www.medicinenet.com/peripheral_vascular_disease/article.htm</a>. Accessed January 5, 2012.</div><br><div id=R22>22.</p><p>Erectile dysfunction. Mayo Clinic Online. <a href=http://www.mayoclinic.com/health/erectile-dysfunction/HB00074>http://www.mayoclinic.com/health/erectile-dysfunction/HB00074</a> Accessed October 25, 2011.</div><br><div id=R23>23.</p><p>Gazzaruso C, Coppola A, Montalcini T, Valenti C, Garzaniti A, Pelissero G, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes</article-title>.</p><p>Endocrine 2011;</p><p>40:273-9; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21861245 target=_blank>21861245</a>; DOI: <a href=http://dx.doi.org/10.1007/s12020-011-9523-9 target=_blank>10.1007/s12020-011-9523-9</a>.</p></div><br><div id=R24>24.<p>Salem S, Abdi S, Mehrsai A, Saboury B, Saraji A, Shokohideh V, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction severity as a risk predictor for coronary artery disease</article-title>.</p><p>J Sex Med 2009;</p><p>6:3425-32; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19796020 target=_blank>19796020</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2009.01515.x target=_blank>10.1111/j.1743-6109.2009.01515.x</a>.</p></div><br><div id=R25>25.<p>Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel</article-title>.</p><p>J Sex Med 2005;</p><p>2:40-50, discussion 50-2; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16422903 target=_blank>16422903</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2005.20104_1.x target=_blank>10.1111/j.1743-6109.2005.20104_1.x</a>.</p></div><br><div id=R26>26.<p>Jackson G, Boon N, Eardley I, Kirby M, Dean J, Hackett G, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus</article-title>.</p><p>Int J Clin Pract 2010;</p><p>64:848-57; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20584218 target=_blank>20584218</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1742-1241.2010.02410.x target=_blank>10.1111/j.1742-1241.2010.02410.x</a>.</p></div><br><div id=R27>27.<p>Polonsky TS, Taillon LA, Sheth H, Min JK, Archer SL, Ward RP.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing</article-title>.</p><p>Atherosclerosis 2009;</p><p>207:440-4; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19501825 target=_blank>19501825</a>; DOI: <a href=http://dx.doi.org/10.1016/j.atherosclerosis.2009.05.005 target=_blank>10.1016/j.atherosclerosis.2009.05.005</a>.</p></div><br><div id=R28>28.<p>Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials</article-title>.</p><p>Circulation 2010;</p><p>121:1439-46; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20231536 target=_blank>20231536</a>; DOI: <a href=http://dx.doi.org/10.1161/CIRCULATIONAHA.109.864199 target=_blank>10.1161/CIRCULATIONAHA.109.864199</a>.</p></div><br><div id=R29>29.<p>Los Angeles Times Online. March 16, 2010. <a href=http://articles.latimes.com/2010/mar/16/science/la-sci-ed-heart16-2010>http://articles.latimes.com/2010/mar/16/science/la-sci-ed-heart16-2010</a> Mar16 Accessed October 26, 2011.</div><br><div id=R30>30.</p><p>Fung MM, Bettencourt R, Barrett-Connor E.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study</article-title>.</p><p>J Am Coll Cardiol 2004;</p><p>43:1405-11; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/15093875 target=_blank>15093875</a>; DOI: <a href=http://dx.doi.org/10.1016/j.jacc.2003.11.041 target=_blank>10.1016/j.jacc.2003.11.041</a>.</p></div><br><div id=R31>31.<p>Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis</article-title>.</p><p>Arch Intern Med 2011;</p><p>171:1797-803; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21911624 target=_blank>21911624</a>; DOI: <a href=http://dx.doi.org/10.1001/archinternmed.2011.440 target=_blank>10.1001/archinternmed.2011.440</a>.</p></div><br><div id=R32>32.<p>Makariou SE, Liberopoulos EN, Agouridis AP, Challa A, Elisaf M.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Effect of Rosuvastatin Monotherapy and in Combination With Fenofibrate or Omega-3 Fatty Acids on Serum Vitamin D Levels</article-title>.</p><p>J Cardiovasc Pharmacol Ther 2012;</p><p>; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22431864 target=_blank>22431864</a>; DOI: <a href=http://dx.doi.org/10.1177/1074248412439470 target=_blank>10.1177/1074248412439470</a>.</p></div><br><div id=R33>33.<p>Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans</article-title>.</p><p>J Am Coll Cardiol 2011;</p><p>58:186-92; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21718915 target=_blank>21718915</a>; DOI: <a href=http://dx.doi.org/10.1016/j.jacc.2011.02.051 target=_blank>10.1016/j.jacc.2011.02.051</a>.</p></div><br><div id=R34>34.<p>Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults</article-title>.</p><p>Hypertension 2011;</p><p>57:63-9; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21115878 target=_blank>21115878</a>; DOI: <a href=http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.160929 target=_blank>10.1161/HYPERTENSIONAHA.110.160929</a>.</p></div><br><div id=R35>35.<p>Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D deficiency and supplementation and relation to cardiovascular health</article-title>.</p><p>Am J Cardiol 2012;</p><p>109:359-63; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22071212 target=_blank>22071212</a>; DOI: <a href=http://dx.doi.org/10.1016/j.amjcard.2011.09.020 target=_blank>10.1016/j.amjcard.2011.09.020</a>.</p></div><br><div id=R36>36.<p>Giovannucci E, Liu Y, Hollis BW, Rimm EB.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>25-hydroxy-vitamin D and risk of myocardial infarction in men</article-title>.</p><p>Ann Intern Med 2008;</p><p>168:1174-80; DOI: <a href=http://dx.doi.org/10.1001/archinte.168.11.1174 target=_blank>10.1001/archinte.168.11.1174</a>.</p></div><br><div id=R37>37.<p>Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Active serum vitamin D levels are inversely correlated with coronary calcification</article-title>.</p><p>Circulation 1997;</p><p>96:1755-60; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/9323058 target=_blank>9323058</a>.</p></div><br><div id=R38>38.<p>Beadenkopf WG, Daoud AS, Love BM.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction</article-title>.</p><p>Am J Roentgenol Radium Ther Nucl Med 1964;</p><p>92:865-71; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/14215099 target=_blank>14215099</a>.</p></div><br><div id=R39>39.<p>Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Quantification of coronary artery calcium using ultrafast computed tomography</article-title>.</p><p>J Am Coll Cardiol 1990;</p><p>15:827-32; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/2407762 target=_blank>2407762</a>; DOI: <a href=http://dx.doi.org/10.1016/0735-1097(90)90282-T target=_blank>10.1016/0735-1097(90)90282-T</a>.</p></div><br><div id=R40>40.<p>Feldman C, Vitola D, Schiavo N.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Detection of coronary artery disease based on the calcification index obtained by helical computed tomography</article-title>.</p><p>Arq Bras Cardiol 2000;</p><p>75:471-80; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/11175472 target=_blank>11175472</a>; DOI: <a href=http://dx.doi.org/10.1590/S0066-782X2000001200002 target=_blank>10.1590/S0066-782X2000001200002</a>.</p></div><br><div id=R41>41.<p>Kitamura A, Kobayashi T, Ueda K, Okada T, Awata N, Sato S, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Evaluation of coronary artery calcification by multi-detector row computed tomography for the detection of coronary artery stenosis in Japanese patients</article-title>.</p><p>J Epidemiol 2005;</p><p>15:187-93; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16195639 target=_blank>16195639</a>; DOI: <a href=http://dx.doi.org/10.2188/jea.15.187 target=_blank>10.2188/jea.15.187</a>.</p></div><br><div id=R42>42.<p>Santos RD, Rumberger JA, Budoff MJ, Shaw LJ, Orakzai SH, Berman D, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Thoracic aorta calcification detected by electron beam tomography predicts all-cause mortality</article-title>.</p><p>Atherosclerosis 2010;</p><p>209:131-5.</p></div><br><div id=R43>43.<p>Jacobs PC, Prokop M, van der Graaf Y, Gondrie MJ, Janssen KJ, de Koning HJ, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers</article-title>.</p><p>Atherosclerosis 2010;</p><p>209:455-62; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19875116 target=_blank>19875116</a>; DOI: <a href=http://dx.doi.org/10.1016/j.atherosclerosis.2009.09.031 target=_blank>10.1016/j.atherosclerosis.2009.09.031</a>.</p></div><br><div id=R44>44.<p>Lee JH, Ngengwe R, Jones P, Tang F, O’Keefe JH.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction as a coronary artery disease risk equivalent</article-title>.</p><p>J Nucl Cardiol 2008;</p><p>15:800-3; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/18984455 target=_blank>18984455</a>.</p></div><br><div id=R45>45.<p>Zittermann A, Schleithoff SS, Koerfer R.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D and vascular calcification</article-title>.</p><p>Curr Opin Lipidol 2007;</p><p>18:41-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/17218831 target=_blank>17218831</a>; DOI: <a href=http://dx.doi.org/10.1097/MOL.0b013e328011c6fc target=_blank>10.1097/MOL.0b013e328011c6fc</a>.</p></div><br><div id=R46>46.<p>National Diabetes Fact Sheet. 2007. Available at <a href=http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf>http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf</a>. Accessed November 25, 2011.</div><br><div id=R47>47.</p><p>Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease</article-title>.</p><p>Arch Intern Med 2007;</p><p>167:1145-51; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/17563022 target=_blank>17563022</a>; DOI: <a href=http://dx.doi.org/10.1001/archinte.167.11.1145 target=_blank>10.1001/archinte.167.11.1145</a>.</p></div><br><div id=R48>48.<p>Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D’Agostino RB.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study</article-title>.</p><p>Circulation 2006;</p><p>113:2914-8; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16785337 target=_blank>16785337</a>; DOI: <a href=http://dx.doi.org/10.1161/CIRCULATIONAHA.106.613828 target=_blank>10.1161/CIRCULATIONAHA.106.613828</a>.</p></div><br><div id=R49>49.<p>Fang J, Alderman MH.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Impact of the increasing burden of diabetes on acute myocardial infarction in New York City: 1990-2000</article-title>.</p><p>Diabetes 2006;</p><p>55:768-73; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16505241 target=_blank>16505241</a>; DOI: <a href=http://dx.doi.org/10.2337/diabetes.55.03.06.db05-1196 target=_blank>10.2337/diabetes.55.03.06.db05-1196</a>.</p></div><br><div id=R50>50.<p>Tousoulis D, Kampoli AM, Stefanadis C.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Diabetes mellitus and vascular endothelial dysfunction: current perspectives</article-title>.</p><p>Curr Vasc Pharmacol 2012;</p><p>10:19-32; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22112354 target=_blank>22112354</a>; DOI: <a href=http://dx.doi.org/10.2174/157016112798829797 target=_blank>10.2174/157016112798829797</a>.</p></div><br><div id=R51>51.<p>De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Endothelial dysfunction in diabetes</article-title>.</p><p>Br J Pharmacol 2000;</p><p>130:963-74; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/10882379 target=_blank>10882379</a>; DOI: <a href=http://dx.doi.org/10.1038/sj.bjp.0703393 target=_blank>10.1038/sj.bjp.0703393</a>.</p></div><br><div id=R52>52.<p>Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Impaired n<b>i</b>tric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus</article-title>.</p><p>J Am Coll Cardiol 1996;</p><p>27:567-74; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/8606266 target=_blank>8606266</a>; DOI: <a href=http://dx.doi.org/10.1016/0735-1097(95)00522-6 target=_blank>10.1016/0735-1097(95)00522-6</a>.</p></div><br><div id=R53>53.<p>Beckman JA, Creager MA, Libby P.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Diabetes and atherosclerosis: epidemiology, pathophysiology, and management</article-title>.</p><p>JAMA 2002;</p><p>287:2570-81; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/12020339 target=_blank>12020339</a>; DOI: <a href=http://dx.doi.org/10.1001/jama.287.19.2570 target=_blank>10.1001/jama.287.19.2570</a>.</p></div><br><div id=R54>54.<p>Awad H, Salem A, Gadalla A, El Wafa NA, Mohamed OA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile function in men with diabetes type 2: correlation with glycemic control</article-title>.</p><p>Int J Impot Res 2010;</p><p>22:36-9; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19759543 target=_blank>19759543</a>; DOI: <a href=http://dx.doi.org/10.1038/ijir.2009.39 target=_blank>10.1038/ijir.2009.39</a>.</p></div><br><div id=R55>55.<p>You RX, McNeil JJ, O’Malley HM, Davis SM, Thrift AG, Donnan GA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Risk factors for stroke due to cerebral infarction in young adults</article-title>.</p><p>Stroke 1997;</p><p>28:1913-8; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/9341695 target=_blank>9341695</a>; DOI: <a href=http://dx.doi.org/10.1161/01.STR.28.10.1913 target=_blank>10.1161/01.STR.28.10.1913</a>.</p></div><br><div id=R56>56.<p>Phé V, Rouprêt M.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies</article-title>.</p><p>Diabetes Metab 2012;</p><p>38:1-13; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22056307 target=_blank>22056307</a>; DOI: <a href=http://dx.doi.org/10.1016/j.diabet.2011.09.003 target=_blank>10.1016/j.diabet.2011.09.003</a>.</p></div><br><div id=R57>57.<p>Selvin E, Burnett AL, Platz EA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Prevalence and risk factors for erectile dysfunction in the US</article-title>.</p><p>Am J Med 2007;</p><p>120:151-7; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/17275456 target=_blank>17275456</a>; DOI: <a href=http://dx.doi.org/10.1016/j.amjmed.2006.06.010 target=_blank>10.1016/j.amjmed.2006.06.010</a>.</p></div><br><div id=R58>58.<p>Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study</article-title>.</p><p>J Urol 2001;</p><p>166:569-74, discussion 574-5; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/11458070 target=_blank>11458070</a>; DOI: <a href=http://dx.doi.org/10.1016/S0022-5347(05)65986-1 target=_blank>10.1016/S0022-5347(05)65986-1</a>.</p></div><br><div id=R59>59.<p>Malavige LS, Levy JC.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction in diabetes mellitus</article-title>.</p><p>J Sex Med 2009;</p><p>6:1232-47; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19210706 target=_blank>19210706</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2008.01168.x target=_blank>10.1111/j.1743-6109.2008.01168.x</a>.</p></div><br><div id=R60>60.<p>Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study</article-title>.</p><p>J Urol 1994;</p><p>151:54-61; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/8254833 target=_blank>8254833</a>.</p></div><br><div id=R61>61.<p>Ishii H, Suzuki H, Baba T, Nakamura K, Watanabe T.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Seasonal variation of glycemic control in type 2 diabetic patients</article-title>.</p><p>Diabetes Care 2001;</p><p>24:1503; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/11473100 target=_blank>11473100</a>; DOI: <a href=http://dx.doi.org/10.2337/diacare.24.8.1503 target=_blank>10.2337/diacare.24.8.1503</a>.</p></div><br><div id=R62>62.<p>Colas C, Garabedian M, Fontbonne A, Guillozo H, Slama G, Desplanque N, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Insulin secretion and plasma 1,25-(OH)2D after UV-B irradiation in healthy adults</article-title>.</p><p>Horm Metab Res 1989;</p><p>21:154-5; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/2663692 target=_blank>2663692</a>; DOI: <a href=http://dx.doi.org/10.1055/s-2007-1009178 target=_blank>10.1055/s-2007-1009178</a>.</p></div><br><div id=R63>63.<p>Pittas AG, Harris SS, Stark PC, Dawson-Hughes B.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults</article-title>.</p><p>Diabetes Care 2007;</p><p>30:980-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/17277040 target=_blank>17277040</a>; DOI: <a href=http://dx.doi.org/10.2337/dc06-1994 target=_blank>10.2337/dc06-1994</a>.</p></div><br><div id=R64>64.<p>Nazarian S, St Peter JV, Boston RC, Jones SA, Mariash CN.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose</article-title>.</p><p>Transl Res 2011;</p><p>158:276-81; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22005267 target=_blank>22005267</a>; DOI: <a href=http://dx.doi.org/10.1016/j.trsl.2011.05.002 target=_blank>10.1016/j.trsl.2011.05.002</a>.</p></div><br><div id=R65>65.<p>Mitri J, Dawson-Hughes B, Hu FB, Pittas AG.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Effects of vitamin D and calcium supplementation on pancreatic ? cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial</article-title>.</p><p>Am J Clin Nutr 2011;</p><p>94:486-94; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21715514 target=_blank>21715514</a>; DOI: <a href=http://dx.doi.org/10.3945/ajcn.111.011684 target=_blank>10.3945/ajcn.111.011684</a>.</p></div><br><div id=R66>66.<p>Bowman TS, Sesso HD, Gaziano JM.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Effect of age on blood pressure parameters and risk of cardiovascular death in men</article-title>.</p><p>Am J Hypertens 2006;</p><p>19:47-52; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16461190 target=_blank>16461190</a>; DOI: <a href=http://dx.doi.org/10.1016/j.amjhyper.2005.06.024 target=_blank>10.1016/j.amjhyper.2005.06.024</a>.</p></div><br><div id=R67>67.<p>Gu D, Kelly TN, Wu X, Chen J, Duan X, Huang JF, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Blood pressure and risk of cardiovascular disease in Chinese men and women</article-title>.</p><p>Am J Hypertens 2008;</p><p>21:265-72; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/18188156 target=_blank>18188156</a>; DOI: <a href=http://dx.doi.org/10.1038/ajh.2007.59 target=_blank>10.1038/ajh.2007.59</a>.</p></div><br><div id=R68>68.<p>Sanford School of Medicine, Stanford Stroke Center. Available online at <a href=http://strokecenter.stanford.edu/guide/prevention.html>http://strokecenter.stanford.edu/guide/prevention.html</a>. Accessed Nov 30, 2011.</div><br><div id=R69>69.</p><p>Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Risk factors</article-title>.</p><p>Stroke 1997;</p><p>38:1507-17.</p></div><br><div id=R70>70.<p>Manolis A, Doumas M.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Sexual dysfunction: the ‘prima ballerina’ of hypertension-related quality-of-life complications</article-title>.</p><p>J Hypertens 2008;</p><p>26:2074-84; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/18854743 target=_blank>18854743</a>; DOI: <a href=http://dx.doi.org/10.1097/HJH.0b013e32830dd0c6 target=_blank>10.1097/HJH.0b013e32830dd0c6</a>.</p></div><br><div id=R71>71.<p>Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Hypertension is associated with severe erectile dysfunction</article-title>.</p><p>J Urol 2000;</p><p>164:1188-91; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/10992363 target=_blank>10992363</a>; DOI: <a href=http://dx.doi.org/10.1016/S0022-5347(05)67138-8 target=_blank>10.1016/S0022-5347(05)67138-8</a>.</p></div><br><div id=R72>72.<p>Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both</article-title>.</p><p>Urology 2004;</p><p>64:1196-201; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/15596196 target=_blank>15596196</a>; DOI: <a href=http://dx.doi.org/10.1016/j.urology.2004.08.059 target=_blank>10.1016/j.urology.2004.08.059</a>.</p></div><br><div id=R73>73.<p>Chung SD, Chen YK, Lin HC, Lin HC.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Increased risk of stroke among men with erectile dysfunction: a nationwide population-based study</article-title>.</p><p>J Sex Med 2011;</p><p>8:240-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20722781 target=_blank>20722781</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2010.01973.x target=_blank>10.1111/j.1743-6109.2010.01973.x</a>.</p></div><br><div id=R74>74.<p>Sigmund CD.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Regulation of renin expression and blood pressure by vitamin D(3)</article-title>.</p><p>J Clin Invest 2002;</p><p>110:155-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/12122105 target=_blank>12122105</a>.</p></div><br><div id=R75>75.<p>Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure</article-title>.</p><p>J Steroid Biochem Mol Biol 2004;</p><p>89-90:387-92; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/15225806 target=_blank>15225806</a>; DOI: <a href=http://dx.doi.org/10.1016/j.jsbmb.2004.03.004 target=_blank>10.1016/j.jsbmb.2004.03.004</a>.</p></div><br><div id=R76>76.<p>Forman JP, Williams JS, Fisher ND.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans</article-title>.</p><p>Hypertension 2010;</p><p>55:1283-8; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20351344 target=_blank>20351344</a>; DOI: <a href=http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.148619 target=_blank>10.1161/HYPERTENSIONAHA.109.148619</a>.</p></div><br><div id=R77>77.<p>Ullah MI, Uwaifo GI, Nicholas WC, Koch CA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Does vitamin d deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms</article-title>.</p><p>Int J Endocrinol 2010;</p><p>:579640.</p></div><br><div id=R78>78.<p>Charach G, Rabinovich PD, Weintraub M.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Seasonal changes in blood pressure and frequency of related complications in elderly Israeli patients with essential hypertension</article-title>.</p><p>Gerontology 2004;</p><p>50:315-21; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/15331861 target=_blank>15331861</a>; DOI: <a href=http://dx.doi.org/10.1159/000079130 target=_blank>10.1159/000079130</a>.</p></div><br><div id=R79>79.<p>Polat M, Akil I, Yuksel H, Coskun S, Yilmaz D, Erguder I, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The effect of seasonal changes on blood pressure and urine specific gravity in children living in Mediterranean climate</article-title>.</p><p>Med Sci Monit 2006;</p><p>12:CR186-90; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16572065 target=_blank>16572065</a>.</p></div><br><div id=R80>80.<p>Krause R, Bühring M, Hopfenmüller W, Holick MF, Sharma AM.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Ultraviolet B and blood pressure</article-title>.</p><p>Lancet 1998;</p><p>352:709-10; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/9728997 target=_blank>9728997</a>; DOI: <a href=http://dx.doi.org/10.1016/S0140-6736(05)60827-6 target=_blank>10.1016/S0140-6736(05)60827-6</a>.</p></div><br><div id=R81>81.<p>Opländer C, Volkmar CM, Paunel-Görgülü A, van Faassen EE, Heiss C, Kelm M, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates</article-title>.</p><p>Circ Res 2009;</p><p>105:1031-40; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19797169 target=_blank>19797169</a>; DOI: <a href=http://dx.doi.org/10.1161/CIRCRESAHA.109.207019 target=_blank>10.1161/CIRCRESAHA.109.207019</a>.</p></div><br><div id=R82>82.<p>Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Plasma 25-hydroxyvitamin D levels and risk of incident hypertension</article-title>.</p><p>Hypertension 2007;</p><p>49:1063-9; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/17372031 target=_blank>17372031</a>; DOI: <a href=http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.087288 target=_blank>10.1161/HYPERTENSIONAHA.107.087288</a>.</p></div><br><div id=R83>83.<p>Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population</article-title>.</p><p>Am J Cardiol 2010;</p><p>106:963-8; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20854958 target=_blank>20854958</a>; DOI: <a href=http://dx.doi.org/10.1016/j.amjcard.2010.05.027 target=_blank>10.1016/j.amjcard.2010.05.027</a>.</p></div><br><div id=R84>84.<p>Trepels T, Zeiher AM, Fichtlscherer S.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The endothelium and inflammation</article-title>.</p><p>Endothelium 2006;</p><p>13:423-9; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/17169774 target=_blank>17169774</a>; DOI: <a href=http://dx.doi.org/10.1080/10623320601061862 target=_blank>10.1080/10623320601061862</a>.</p></div><br><div id=R85>85.<p>Manabe I.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Chronic inflammation links cardiovascular, metabolic and renal diseases</article-title>.</p><p>Circ J 2011;</p><p>75:2739-48; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22067929 target=_blank>22067929</a>; DOI: <a href=http://dx.doi.org/10.1253/circj.CJ-11-1184 target=_blank>10.1253/circj.CJ-11-1184</a>.</p></div><br><div id=R86>86.<p>Libby P, Okamoto Y, Rocha VZ, Folco E.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Inflammation in atherosclerosis: transition from theory to practice</article-title>.</p><p>Circ J 2010;</p><p>74:213-20; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20065609 target=_blank>20065609</a>; DOI: <a href=http://dx.doi.org/10.1253/circj.CJ-09-0706 target=_blank>10.1253/circj.CJ-09-0706</a>.</p></div><br><div id=R87>87.<p>Libby P.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Inflammation and cardiovascular disease mechanisms</article-title>.</p><p>Am J Clin Nutr 2006;</p><p>83:456S-60S; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16470012 target=_blank>16470012</a>.</p></div><br><div id=R88>88.<p>Cybulsky MI, Gimbrone MA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis</article-title>.</p><p>Science 1991;</p><p>251:788-91; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/1990440 target=_blank>1990440</a>; DOI: <a href=http://dx.doi.org/10.1126/science.1990440 target=_blank>10.1126/science.1990440</a>.</p></div><br><div id=R89>89.<p>Li H, Cybulsky MI, Gimbrone MA, Libby P.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma</article-title>.</p><p>Am J Pathol 1993;</p><p>143:1551-9; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/7504883 target=_blank>7504883</a>.</p></div><br><div id=R90>90.<p>Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice</article-title>.</p><p>Mol Cell 1998;</p><p>2:275-81; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/9734366 target=_blank>9734366</a>; DOI: <a href=http://dx.doi.org/10.1016/S1097-2765(00)80139-2 target=_blank>10.1016/S1097-2765(00)80139-2</a>.</p></div><br><div id=R91>91.<p>Boring L, Gosling J, Cleary M, Charo IF.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis</article-title>.</p><p>Nature 1998;</p><p>394:894-7; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/9732872 target=_blank>9732872</a>; DOI: <a href=http://dx.doi.org/10.1038/29788 target=_blank>10.1038/29788</a>.</p></div><br><div id=R92>92.<p>Chiurlia E, D’Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Subclinical coronary artery atherosclerosis in patients with erectile dysfunction</article-title>.</p><p>J Am Coll Cardiol 2005;</p><p>46:1503-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16226175 target=_blank>16226175</a>; DOI: <a href=http://dx.doi.org/10.1016/j.jacc.2005.06.068 target=_blank>10.1016/j.jacc.2005.06.068</a>.</p></div><br><div id=R93>93.<p>Zambon JP, Mendonça RR, Wroclawski ML, Karam Junior A, Santos RD, Carvalho JA, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: case-control study</article-title>.</p><p>Sao Paulo Med J 2010;</p><p>128:137-40; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20963365 target=_blank>20963365</a>; DOI: <a href=http://dx.doi.org/10.1590/S1516-31802010000300006 target=_blank>10.1590/S1516-31802010000300006</a>.</p></div><br><div id=R94>94.<p>Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis</article-title>.</p><p>Circulation 2002;</p><p>106:913-9; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/12186793 target=_blank>12186793</a>; DOI: <a href=http://dx.doi.org/10.1161/01.CIR.0000029802.88087.5E target=_blank>10.1161/01.CIR.0000029802.88087.5E</a>.</p></div><br><div id=R95>95.<p>Bocchio M, Desideri G, Scarpelli P, Necozione S, Properzi G, Spartera C, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage</article-title>.</p><p>J Urol 2004;</p><p>171:1601-4; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/15017230 target=_blank>15017230</a>; DOI: <a href=http://dx.doi.org/10.1097/01.ju.0000116325.06572.85 target=_blank>10.1097/01.ju.0000116325.06572.85</a>.</p></div><br><div id=R96>96.<p>Carneiro FS, Webb RC, Tostes RC.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Emerging role for TNF-? in erectile dysfunction</article-title>.</p><p>J Sex Med 2010;</p><p>7:3823-34; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20345734 target=_blank>20345734</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2010.01762.x target=_blank>10.1111/j.1743-6109.2010.01762.x</a>.</p></div><br><div id=R97>97.<p>Guillot X, Semerano L, Saidenberg-Kermanac’h N, Falgarone G, Boissier MC.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D and inflammation</article-title>.</p><p>Joint Bone Spine 2010;</p><p>77:552-7; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21067953 target=_blank>21067953</a>; DOI: <a href=http://dx.doi.org/10.1016/j.jbspin.2010.09.018 target=_blank>10.1016/j.jbspin.2010.09.018</a>.</p></div><br><div id=R98>98.<p>Zittermann A, Schleithoff SS, Koerfer R.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Putting cardiovascular disease and vitamin D insufficiency into perspective</article-title>.</p><p>Br J Nutr 2005;</p><p>94:483-92; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16197570 target=_blank>16197570</a>; DOI: <a href=http://dx.doi.org/10.1079/BJN20051544 target=_blank>10.1079/BJN20051544</a>.</p></div><br><div id=R99>99.<p>Müller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level</article-title>.</p><p>Cytokine 1992;</p><p>4:506-12; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/1337987 target=_blank>1337987</a>; DOI: <a href=http://dx.doi.org/10.1016/1043-4666(92)90012-G target=_blank>10.1016/1043-4666(92)90012-G</a>.</p></div><br><div id=R100>100.<p>Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial</article-title>.</p><p>Am J Clin Nutr 2006;</p><p>83:731-2; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16600920 target=_blank>16600920</a>.</p></div><br><div id=R101>101.<p>Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes</article-title>.</p><p>Eur J Endocrinol 2001;</p><p>145:351-7; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/11517017 target=_blank>11517017</a>; DOI: <a href=http://dx.doi.org/10.1530/eje.0.1450351 target=_blank>10.1530/eje.0.1450351</a>.</p></div><br><div id=R102>102.<p>Peterson CA, Heffernan ME.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women</article-title>.</p><p>J Inflamm (Lond) 2008;</p><p>5:10; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/18652680 target=_blank>18652680</a>; DOI: <a href=http://dx.doi.org/10.1186/1476-9255-5-10 target=_blank>10.1186/1476-9255-5-10</a>.</p></div><br><div id=R103>103.<p>Martinesi M, Bruni S, Stio M, Treves C.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>1,25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells</article-title>.</p><p>Cell Biol Int 2006;</p><p>30:365-75; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/16549374 target=_blank>16549374</a>; DOI: <a href=http://dx.doi.org/10.1016/j.cellbi.2006.01.004 target=_blank>10.1016/j.cellbi.2006.01.004</a>.</p></div><br><div id=R104>104.<p>Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus</article-title>.</p><p>Circulation 2009;</p><p>120:687-98; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19667238 target=_blank>19667238</a>; DOI: <a href=http://dx.doi.org/10.1161/CIRCULATIONAHA.109.856070 target=_blank>10.1161/CIRCULATIONAHA.109.856070</a>.</p></div><br><div id=R105>105.<p>Riek AE, Oh J, Bernal-Mizrachi C.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D regulates macrophage cholesterol metabolism in diabetes</article-title>.</p><p>J Steroid Biochem Mol Biol 2010;</p><p>121:430-3; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20338238 target=_blank>20338238</a>; DOI: <a href=http://dx.doi.org/10.1016/j.jsbmb.2010.03.018 target=_blank>10.1016/j.jsbmb.2010.03.018</a>.</p></div><br><div id=R106>106.<p>Yiu YF, Chan YH, Yiu KH, Siu CW, Li SW, Wong LY, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes</article-title>.</p><p>J Clin Endocrinol Metab 2011;</p><p>96:E830-5; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21325459 target=_blank>21325459</a>; DOI: <a href=http://dx.doi.org/10.1210/jc.2010-2212 target=_blank>10.1210/jc.2010-2212</a>.</p></div><br><div id=R107>107.<p>Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line</article-title>.</p><p>Infect Immun 1998;</p><p>66:5314-21; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/9784538 target=_blank>9784538</a>.</p></div><br><div id=R108>108.<p>Willems HM, van den Heuvel EG, Carmeliet G, Schaafsma A, Klein-Nulend J, Bakker AD.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts</article-title>.</p><p>Steroids 2012;</p><p>77:126-31; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22093484 target=_blank>22093484</a>; DOI: <a href=http://dx.doi.org/10.1016/j.steroids.2011.10.015 target=_blank>10.1016/j.steroids.2011.10.015</a>.</p></div><br><div id=R109>109.<p>Molinari C, Uberti F, Grossini E, Vacca G, Carda S, Invernizzi M, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>1?,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells</article-title>.</p><p>Cell Physiol Biochem 2011;</p><p>27:661-8; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21691084 target=_blank>21691084</a>; DOI: <a href=http://dx.doi.org/10.1159/000330075 target=_blank>10.1159/000330075</a>.</p></div><br><div id=R110>110.<p>Tare M, Emmett SJ, Coleman HA, Skordilis C, Eyles DW, Morley R, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats</article-title>.</p><p>J Physiol 2011;</p><p>589:4777-86; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21807617 target=_blank>21807617</a>; DOI: <a href=http://dx.doi.org/10.1113/jphysiol.2011.214726 target=_blank>10.1113/jphysiol.2011.214726</a>.</p></div><br><div id=R111>111.<p>Chua GT, Chan YC, Cheng SW.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D status and peripheral arterial disease: evidence so far</article-title>.</p><p>Vasc Health Risk Manag 2011;</p><p>7:671-5; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22140318 target=_blank>22140318</a>.</p></div><br><div id=R112>112.<p>Stach K, Kälsch AI, Nguyen XD, Elmas E, Kralev S, Lang S, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>1?,25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells</article-title>.</p><p>Cardiology 2011;</p><p>118:107-15; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21546774 target=_blank>21546774</a>; DOI: <a href=http://dx.doi.org/10.1159/000327547 target=_blank>10.1159/000327547</a>.</p></div><br><div id=R113>113.<p>Nathan Seppa, Science News December 17, 2011, reporting on AHA Scientific sessions: Arnson Y, Amital H, Mosseri M. Short-term vitamin D inhibits the increase in inflammatory cytokine and adhesion molecule levels in patients after a coronary event. Abstract # 11373. American Heart Association Scientific Sessions, November 12, 2011, Orlando, Fla.</div><br><div id=R114>114.</p><p>Chen S, Law CS, Gardner DG.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of cdk2 activity</article-title>.</p><p>J Steroid Biochem Mol Biol 2010;</p><p>122:326-32; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/20813185 target=_blank>20813185</a>; DOI: <a href=http://dx.doi.org/10.1016/j.jsbmb.2010.08.007 target=_blank>10.1016/j.jsbmb.2010.08.007</a>.</p></div><br><div id=R115>115.<p>Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, Sharon O, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>25-hydroxyvitamin D3-1?-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds</article-title>.</p><p>Circulation 2005;</p><p>111:1666-71; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/15795327 target=_blank>15795327</a>; DOI: <a href=http://dx.doi.org/10.1161/01.CIR.0000160353.27927.70 target=_blank>10.1161/01.CIR.0000160353.27927.70</a>.</p></div><br><div id=R116>116.<p>Laumann EO, West S, Glasser D, Carson C, Rosen R, Kang JH.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Prevalence and correlates of erectile dysfunction by race and ethnicity among men aged 40 or older in the United States: from the male attitudes regarding sexual health survey</article-title>.</p><p>J Sex Med 2007;</p><p>4:57-65; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/17081223 target=_blank>17081223</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2006.00340.x target=_blank>10.1111/j.1743-6109.2006.00340.x</a>.</p></div><br><div id=R117>117.<p>Kupelian V, Link CL, Rosen RC, McKinlay JB.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Socioeconomic status, not race/ethnicity, contributes to variation in the prevalence of erectile dysfunction: results from the Boston Area Community Health (BACH) Survey</article-title>.</p><p>J Sex Med 2008;</p><p>5:1325-33; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/18410305 target=_blank>18410305</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2008.00822.x target=_blank>10.1111/j.1743-6109.2008.00822.x</a>.</p></div><br><div id=R118>118.<p>Zeiss AM, Davies HD, Wood M, Tinklenberg JR.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The incidence and correlates of erectile problems in patients with Alzheimer’s disease</article-title>.</p><p>Arch Sex Behav 1990;</p><p>19:325-31; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/2400296 target=_blank>2400296</a>; DOI: <a href=http://dx.doi.org/10.1007/BF01541927 target=_blank>10.1007/BF01541927</a>.</p></div><br><div id=R119>119.<p>Grant WB.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Does vitamin D reduce the risk of dementia?</article-title>.</p><p>J Alzheimers Dis 2009;</p><p>17:151-9; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19494440 target=_blank>19494440</a>.</p></div><br><div id=R120>120.<p>Chou KT, Huang CC, Chen YM, Perng DW, Chao HS, Chan WL, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Asthma and risk of erectile dysfunction&ndash;a nationwide population-based study</article-title>.</p><p>J Sex Med 2011;</p><p>8:1754-60; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21426497 target=_blank>21426497</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2011.02242.x target=_blank>10.1111/j.1743-6109.2011.02242.x</a>.</p></div><br><div id=R121>121.<p>Bozzetto S, Carraro S, Giordano G, Boner A, Baraldi E.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Asthma, allergy and respiratory infections: the vitamin D hypothesis</article-title>.</p><p>Allergy 2012;</p><p>67:10-7; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21933195 target=_blank>21933195</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1398-9995.2011.02711.x target=_blank>10.1111/j.1398-9995.2011.02711.x</a>.</p></div><br><div id=R122>122.<p>Malekmakan L, Shakeri S, Haghpanah S, Pakfetrat M, Sarvestani AS, Malekmakan A.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Epidemiology of erectile dysfunction in hemodialysis patients using IIEF questionnaire</article-title>.</p><p>Saudi J Kidney Dis Transpl 2011;</p><p>22:232-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21422619 target=_blank>21422619</a>.</p></div><br><div id=R123>123.<p>Kim HS, Chung W, Kim S.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin d, and kidney disease</article-title>.</p><p>Electrolyte Blood Press 2011;</p><p>9:1-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21998600 target=_blank>21998600</a>; DOI: <a href=http://dx.doi.org/10.5049/EBP.2011.9.1.1 target=_blank>10.5049/EBP.2011.9.1.1</a>.</p></div><br><div id=R124>124.<p>Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies</article-title>.</p><p>Am J Kidney Dis 2011;</p><p>58:374-82; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21636193 target=_blank>21636193</a>.</p></div><br><div id=R125>125.<p>Perelman MA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction and depression: screening and treatment</article-title>.</p><p>Urol Clin North Am 2011;</p><p>38:125-39; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21621079 target=_blank>21621079</a>; DOI: <a href=http://dx.doi.org/10.1016/j.ucl.2011.03.004 target=_blank>10.1016/j.ucl.2011.03.004</a>.</p></div><br><div id=R126>126.<p>Hoang MT, Defina LF, Willis BL, Leonard DS, Weiner MF, Brown ES.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study</article-title>.</p><p>Mayo Clin Proc 2011;</p><p>86:1050-5; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22033249 target=_blank>22033249</a>; DOI: <a href=http://dx.doi.org/10.4065/mcp.2011.0208 target=_blank>10.4065/mcp.2011.0208</a>.</p></div><br><div id=R127>127.<p>Frost M, Abrahamsen B, Masud T, Brixen K.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Risk factors for fracture in elderly men: a population-based prospective study</article-title>.</p><p>Osteoporos Int 2012;</p><p>23:521-31; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21409435 target=_blank>21409435</a>; DOI: <a href=http://dx.doi.org/10.1007/s00198-011-1575-4 target=_blank>10.1007/s00198-011-1575-4</a>.</p></div><br><div id=R128>128.<p>Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials</article-title>.</p><p>JAMA 2005;</p><p>293:2257-64; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/15886381 target=_blank>15886381</a>; DOI: <a href=http://dx.doi.org/10.1001/jama.293.18.2257 target=_blank>10.1001/jama.293.18.2257</a>.</p></div><br><div id=R129>129.<p>Lee RK, Chughtai B, Te AE, Kaplan SA.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Sexual function in men with metabolic syndrome</article-title>.</p><p>Urol Clin North Am 2012;</p><p>39:53-62; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22118345 target=_blank>22118345</a>; DOI: <a href=http://dx.doi.org/10.1016/j.ucl.2011.09.008 target=_blank>10.1016/j.ucl.2011.09.008</a>.</p></div><br><div id=R130>130.<p>Al-Daghri NM, Alkharfy KM, Al-Saleh Y, Al-Attas OS, Alokail MS, Al-Othman A, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study</article-title>.</p><p>Metabolism 2011;</p><p>; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22075268 target=_blank>22075268</a>; DOI: <a href=http://dx.doi.org/10.1016/j.metabol.2011.09.017 target=_blank>10.1016/j.metabol.2011.09.017</a>.</p></div><br><div id=R131>131.<p>Severson B. Sexual Dysfunction and Multiple Sclerosis. U.S. Dept. of Veterans Affairs, Multiple Sclerosis Center of Excellence. 2010. Available at <a href=http://www.va.gov/MS/articles/Sexual_Dysfunction_and_Multiple_Sclerosis.asp>http://www.va.gov/MS/articles/Sexual_Dysfunction_and_Multiple_Sclerosis.asp</a>. Accessed Dec 27, 2011.</div><br><div id=R132>132.</p><p>Boston Medical Group Online. Multiple Sclerosis and Erectile dysfunction. <a href=http://www.multiplesclerosiserectiledysfunction.com/>http://www.multiplesclerosiserectiledysfunction.com/</a> Accessed December 27, 2011.</div><br><div id=R133>133.</p><p>Munger KL, Zhang SM, O’Reilly E, Hernán MA, Olek MJ, Willett WC, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin D intake and incidence of multiple sclerosis</article-title>.</p><p>Neurology 2004;</p><p>62:60-5; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/14718698 target=_blank>14718698</a>.</p></div><br><div id=R134>134.<p>Mirzaei F, Michels KB, Munger K, O’Reilly E, Chitnis T, Forman MR, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Gestational vitamin D and the risk of multiple sclerosis in offspring</article-title>.</p><p>Ann Neurol 2011;</p><p>70:30-40; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21786297 target=_blank>21786297</a>; DOI: <a href=http://dx.doi.org/10.1002/ana.22456 target=_blank>10.1002/ana.22456</a>.</p></div><br><div id=R135>135.<p>Chao JK, Hwang TI, Ma MC, Kuo WH, Liu JH, Chen YP, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>A survey of obesity and erectile dysfunction of men conscripted into the military in Taiwan</article-title>.</p><p>J Sex Med 2011;</p><p>8:1156-63; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21269394 target=_blank>21269394</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2010.02181.x target=_blank>10.1111/j.1743-6109.2010.02181.x</a>.</p></div><br><div id=R136>136.<p>Earthman CP, Beckman LM, Masodkar K, Sibley SD.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications</article-title>.</p><p>Int J Obes (Lond) 2012;</p><p>36:387-96; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21694701 target=_blank>21694701</a>; DOI: <a href=http://dx.doi.org/10.1038/ijo.2011.119 target=_blank>10.1038/ijo.2011.119</a>.</p></div><br><div id=R137>137.<p>Roumiguié M, Guillotreau J, Castel-Lacanal E, Malavaud B, De Boissezon X, Marque P, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>[Assessment of sexual function in men with idiopathic Parkinson’s disease using the International Index of Erectile Dysfunction (IIEF-15)]</article-title>.</p><p>Prog Urol 2011;</p><p>21:67-71; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21193148 target=_blank>21193148</a>.</p></div><br><div id=R138>138.<p>Evatt ML, DeLong MR, Kumari M, Auinger P, McDermott MP, Tangpricha V.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>High prevalence of hypovitaminosis D status in patients with early Parkinson disease</article-title>.</p><p>Arch Neurol 2011;</p><p>68:314-9; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21403017 target=_blank>21403017</a>; DOI: <a href=http://dx.doi.org/10.1001/archneurol.2011.30 target=_blank>10.1001/archneurol.2011.30</a>.</p></div><br><div id=R139>139.<p>Zadik Y, Bechor R, Galor S, Justo D, Heruti RJ.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Erectile dysfunction might be associated with chronic periodontal disease: two ends of the cardiovascular spectrum</article-title>.</p><p>J Sex Med 2009;</p><p>6:1111-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/19170861 target=_blank>19170861</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2008.01141.x target=_blank>10.1111/j.1743-6109.2008.01141.x</a>.</p></div><br><div id=R140>140.<p>Grant WB, Boucher BJ.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Are Hill’s criteria for causality satisfied for vitamin D and periodontal disease<i>?</i></article-title>.</p><p>Dermatoendocrinol 2010;</p><p>2:30-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21547146 target=_blank>21547146</a>; DOI: <a href=http://dx.doi.org/10.4161/derm.2.1.12488 target=_blank>10.4161/derm.2.1.12488</a>.</p></div><br><div id=R141>141.<p>Chung SD, Keller JJ, Chu TW, Lin HC.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Psoriasis and the risk of erectile dysfunction: a population-based case-control study</article-title>.</p><p>J Sex Med 2012;</p><p>9:130-5; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22023713 target=_blank>22023713</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2011.02510.x target=_blank>10.1111/j.1743-6109.2011.02510.x</a>.</p></div><br><div id=R142>142.<p>Rácz E, Prens EP, Kurek D, Kant M, de Ridder D, Mourits S, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways</article-title>.</p><p>J Invest Dermatol 2011;</p><p>131:1547-58; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/21412260 target=_blank>21412260</a>; DOI: <a href=http://dx.doi.org/10.1038/jid.2011.53 target=_blank>10.1038/jid.2011.53</a>.</p></div><br><div id=R143>143.<p>Safarinejad MR.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Prevalence and risk factors for erectile dysfunction in a population-based study in Iran</article-title>.</p><p>Int J Impot Res 2003;</p><p>15:246-52; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/12934051 target=_blank>12934051</a>; DOI: <a href=http://dx.doi.org/10.1038/sj.ijir.3901024 target=_blank>10.1038/sj.ijir.3901024</a>.</p></div><br><div id=R144>144.<p>Brot C, Jorgensen NR, Sorensen OH.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>The influence of smoking on vitamin D status and calcium metabolism</article-title>.</p><p>Eur J Clin Nutr 1999;</p><p>53:920-6; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/10602348 target=_blank>10602348</a>; DOI: <a href=http://dx.doi.org/10.1038/sj.ejcn.1600870 target=_blank>10.1038/sj.ejcn.1600870</a>.</p></div><br><div id=R145>145.<p>Chung SD, Keller JJ, Lin HC.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Association of erectile dysfunction with atopic dermatitis: a population-based case-control study</article-title>.</p><p>J Sex Med 2012;</p><p>9:679-85; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22240253 target=_blank>22240253</a>; DOI: <a href=http://dx.doi.org/10.1111/j.1743-6109.2011.02587.x target=_blank>10.1111/j.1743-6109.2011.02587.x</a>.</p></div><br><div id=R146>146.<p>Amestejani M, Salehi BS, Vasigh M, Sobhkhiz A, Karami M, Alinia H, et al.</p><p><article-title xmlns:oasis=http://docs.oasis-open.org/ns/oasis-exchange/table>Vitamin d supplementation in the treatment of atopic dermatitis: a clinical trial study</article-title>.</p><p>J Drugs Dermatol 2012;</p><p>11:327-30; PMID: <a href=http://www.ncbi.nlm.nih.gov/pubmed/22395583 target=_blank>22395583</a>.</p></div><br><div id=R147>147.<p>Drugs.com. Viagra Side Effects. <a href=http://www.drugs.com/sfx/viagra-side-effects.html>http://www.drugs.com/sfx/viagra-side-effects.html</a>. Accessed Dec. 20, 2011.</div><br></div><img src="./dertmato 7_files/delete.png" style=display:inline role=.license><h4 class=section_title style=font-weight:700;color:#654d3e>License</h4><br><br><div class=license><a rel=license href=http://creativecommons.org/licenses/by-nc/3.0/><img alt="Creative Commons License" style=border-width:0 src="./dertmato 7_files/88x31.png"></a><br>This is an Open Access article licensed under a <a rel=license href=http://creativecommons.org/licenses/by-nc/3.0/>Creative Commons Attribution-NonCommercial 3.0 Unported License</a>. The article may be redistributed, reproduced and reused for non-commercial purposes, provided the original source is properly cited.</p></div></div><div id=step_top class=top_return style=cursor:pointer;color:#804000;font-weight:700;display:none><div style="padding:10px 0">Top</div></div><div id=step_back class=top_return style=top:80px;left:20px;cursor:pointer;color:#804000;font-weight:700><div style="padding:10px 0">Back</div></div><div id=section_jump class=top_return style=top:140px;display:inline;height:auto;width:auto><table style=margin-top:20px><tbody><tr><td style=border-right-width:6px;border-right-style:double;border-right-color:#ddd;display:none><ul style=white-space:nowrap;padding-right:40px><li style=padding-top:5px;padding-right:5px;padding-bottom:5px;padding-left:5px;cursor:pointer;color:#804000><img src="./dertmato 7_files/delete.png" style=display:inline role=.section_1>Introduction: Important facts pertaining to this discussion</li><li style=padding-top:5px;padding-right:5px;padding-bottom:5px;padding-left:5px;cursor:pointer;color:#804000><img src="./dertmato 7_files/delete.png" style=display:inline role=.section_2>The role of vascular disorders in ED</li><li style=padding-top:5px;padding-right:5px;padding-bottom:5px;padding-left:5px;cursor:pointer;color:#804000><img src="./dertmato 7_files/delete.png" style=display:inline role=.section_3>The role of vitamin D and sunlight on CVD</li><li style=padding-top:5px;padding-right:5px;padding-bottom:5px;padding-left:5px;cursor:pointer;color:#804000><img src="./dertmato 7_files/delete.png" style=display:inline role=.section_4>Possible influence of sunlight or vitamin D on four major risk factors for CVD and ED</li><li style=padding-top:5px;padding-right:5px;padding-bottom:5px;padding-left:5px;cursor:pointer;color:#804000><img src="./dertmato 7_files/delete.png" style=display:inline role=.section_5>Conclusion</li><li style=padding-top:5px;padding-right:5px;padding-bottom:5px;padding-left:5px;cursor:pointer;color:#804000><img src="./dertmato 7_files/delete.png" style=display:inline role=.references>References</li><li style=padding-top:5px;padding-right:5px;padding-bottom:5px;padding-left:5px;cursor:pointer;color:#804000><img src="./dertmato 7_files/delete.png" style=display:inline role=.license>License</li></ul></td><td id=jump_button style=vertical-align:top;width:65px;text-align:center;cursor:pointer;color:#804000;font-weight:700><div id=jump_text>Jump to Section</div></td></tr></tbody></table></div><hr class=space></div></div><div id=landes_content_east class="span-4 last prepend-top append-bottom"><p><span class=small style=color:#bbb>Advertisements</span></p><div id=lbsmod3204 class="landes_component full_block banner_ad clearfix append-bottom"><p><a href=http://www.ithenticate.com/ onclick='pageTracker._trackPageview("/bannerads/ithenticate/ithenticate")' target=_blank><img src="./dertmato 7_files/iThenticate-Button-21.png"></a></p></div><div id=lbsmod3366 class="landes_component full_block banner_ad clearfix append-bottom"><p><a href="http://itunes.apple.com/us/app/landes-bioscience/id413237470?mt=8&ls=1" onclick='pageTracker._trackPageview("/bannerads/Landes/ipad App 2.0 AD")' target=_blank><img src="./dertmato 7_files/ipad2_ad.gif"></a></p></div><div id=lbsmod2671 class="landes_component full_block banner_ad clearfix append-bottom"><p><a href=https://www.landesbioscience.com/journals/rss/ onclick='pageTracker._trackPageview("/bannerads/Landes/lb-rss")' target=_blank><img src="./dertmato 7_files/LB-RSS-webAd_2.gif"></a></p></div><div id=lbsmod1943 class="landes_component full_block banner_ad clearfix append-bottom"><p><a href=https://www.landesbioscience.com/jobs/ onclick='pageTracker._trackPageview("/bannerads/Landes/job_search")' target=_blank><img src="./dertmato 7_files/Job-Search.gif"></a></p></div><div id=lbsmod897 class="landes_component full_block banner_ad clearfix append-bottom"><p><a href=https://www.who.int/hinari/about/en/ onclick='pageTracker._trackPageview("/bannerads/Landes/HInari")' target=_blank><img src="./dertmato 7_files/hinari-new.jpg"></a></p></div></div></div></div></div><div id=landes_footer style=height:90px><div style=text-align:center class="prepend-top append-bottom clearfix"><ul id=landes_footer_nav class=clearfix><li><a href=http://www.landesbioscience.com/contact/>Contact Us</a></li><li><a href=http://www.landesbioscience.com/user_agreement/>Terms and Agreement</a></li><li><a href=mailto:info@landesbioscience.com>Feedback</a></li><li><a href=http://www.landesbioscience.com/journals/advertising/>Advertising</a></li><li><span>You are accessing our site from 71.212.110.83</span></li></ul></div><div style=height:20px class="append-bottom clearfix"><ul id=landes_footer_list class=clearfix><li>© Landes Bioscience</li><li>1806 Rio Grande St., Austin, TX 78701</li><li>ph: 512.637.6050</li><li>fax: 512.637.6079</li></ul></div></div><script type=text/javascript>NREUMQ.f||(NREUMQ.f=function(){NREUMQ.push(["load",(new Date).getTime()]);var e=document.createElement("script");e.type="text/javascript",e.async=!0,e.src="https://d1ros97qkrwjf5.cloudfront.net/30/eum/rum.js",document.body.appendChild(e),NREUMQ.a&&NREUMQ.a()},NREUMQ.a=window.onload,window.onload=NREUMQ.f),NREUMQ.push(["nrf2","beacon-1.newrelic.com","ac71ba990c",603060,"ZQNWMkpYXhUHAkZZXFxJYRRRFlkIAgRKHkNaFg==",0,249,(new Date).getTime()])</script><script type=text/javascript async src="./dertmato 7_files/rum.js"></script><script id=nreum-send-beacon type=text/x-nreum-data></script></body></html></div><hr class=tag-separator><div class=tags><span>Tags: </span><span class=tag>asthma</span>
<span class=tag>asthma receptor</span>
<span class=tag>atherosclerosis</span>
<span class=tag>atopic dermatitis</span>
<span class=tag>autoimmune</span>
<span class=tag>bacteria</span>
<span class=tag>blood levels</span>
<span class=tag>bone</span>
<span class=tag>bone cancer</span>
<span class=tag>brain</span>
<span class=tag>breathing</span>
<span class=tag>cancer</span>
<span class=tag>cancer in VDR</span>
<span class=tag>cardiovascular</span>
<span class=tag>child</span>
<span class=tag>childhood cancer</span>
<span class=tag>childhood obesity</span>
<span class=tag>childhood respiratory</span>
<span class=tag>childhood viruses</span>
<span class=tag>cholesterol</span>
<span class=tag>CKD</span>
<span class=tag>cognitive</span>
<span class=tag>dementia</span>
<span class=tag>depression</span>
<span class=tag>dermatology</span>
<span class=tag>diabetes</span>
<span class=tag>diabetes and vitamin d receptor</span>
<span class=tag>dosage</span>
<span class=tag>epilepsy</span>
<span class=tag>falls fractures</span>
<span class=tag>Fertility and sperm</span>
<span class=tag>genetics</span>
<span class=tag>health risk</span>
<span class=tag>heart failure</span>
<span class=tag>hemodialysis</span>
<span class=tag>high dose</span>
<span class=tag>hypertension</span>
<span class=tag>intervention</span>
<span class=tag>kidney</span>
<span class=tag>life span</span>
<span class=tag>metabolic</span>
<span class=tag>metabolic conditions</span>
<span class=tag>metabolic syndrome</span>
<span class=tag>mood disorders</span>
<span class=tag>mortality</span>
<span class=tag>multiple sclerosis</span>
<span class=tag>neurological</span>
<span class=tag>obesity</span>
<span class=tag>obesity and cancer</span>
<span class=tag>obesity and vitamin d receptor</span>
<span class=tag>omega 3</span>
<span class=tag>omega 3 and viruses</span>
<span class=tag>pain</span>
<span class=tag>pediatric autoimmune</span>
<span class=tag>psoriasis</span>
<span class=tag>respiratory</span>
<span class=tag>rheumatoid arthritis</span>
<span class=tag>smoking</span>
<span class=tag>statins</span>
<span class=tag>stroke</span>
<span class=tag>stroke and depression</span>
<span class=tag>therapeutic intervention</span>
<span class=tag>tuberculosis</span>
<span class=tag>ultraviolet light</span>
<span class=tag>virus</span>
<span class=tag>virus and cardiovascular</span>
<span class=tag>virus and cognitive</span>
<span class=tag>virus and obesity</span>
<span class=tag>viruses and vitamin d receptor</span>
<span class=tag>vitamin d</span>
<span class=tag>vitamin d and viruses</span>
<span class=tag>vitamin d blood test</span>
<span class=tag>vitamin d receptor</span></div><div data-pagefind-meta=tags hidden>asthma, asthma receptor, atherosclerosis, atopic dermatitis, autoimmune, bacteria, blood levels, bone, bone cancer, brain, breathing, cancer, cancer in VDR, cardiovascular, child, childhood cancer, childhood obesity, childhood respiratory, childhood viruses, cholesterol, CKD, cognitive, dementia, depression, dermatology, diabetes, diabetes and vitamin d receptor, dosage, epilepsy, falls fractures, Fertility and sperm, genetics, health risk, heart failure, hemodialysis, high dose, hypertension, intervention, kidney, life span, metabolic, metabolic conditions, metabolic syndrome, mood disorders, mortality, multiple sclerosis, neurological, obesity, obesity and cancer, obesity and vitamin d receptor, omega 3, omega 3 and viruses, pain, pediatric autoimmune, psoriasis, respiratory, rheumatoid arthritis, smoking, statins, stroke, stroke and depression, therapeutic intervention, tuberculosis, ultraviolet light, virus, virus and cardiovascular, virus and cognitive, virus and obesity, viruses and vitamin d receptor, vitamin d, vitamin d and viruses, vitamin d blood test, vitamin d receptor</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1752030351"></script><script src="/js/tiki-redirects.js?v=1752030351"></script><script src="/js/lightspa.js?v=1752030351"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1752030351",indexUrl:"/search/search_index.json.gz?v=1752030351"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1752030351"></script></body></html>